Document_and_Entity_Informatio
Document and Entity Information | 3 Months Ended | ||
Sep. 30, 2013 | Oct. 24, 2013 | Oct. 24, 2013 | |
Common Class A | Common Class B | ||
Entity Registrant Name | 'ESTEE LAUDER COMPANIES INC | ' | ' |
Entity Central Index Key | '0001001250 | ' | ' |
Document Type | '10-Q | ' | ' |
Document Period End Date | 30-Sep-13 | ' | ' |
Amendment Flag | 'false | ' | ' |
Current Fiscal Year End Date | '--06-30 | ' | ' |
Entity Current Reporting Status | 'Yes | ' | ' |
Entity Filer Category | 'Large Accelerated Filer | ' | ' |
Entity Common Stock, Shares Outstanding | ' | 239,225,209 | 148,728,082 |
Document Fiscal Year Focus | '2014 | ' | ' |
Document Fiscal Period Focus | 'Q1 | ' | ' |
CONSOLIDATED_STATEMENTS_OF_EAR
CONSOLIDATED STATEMENTS OF EARNINGS (USD $) | 3 Months Ended | |
In Millions, except Per Share data, unless otherwise specified | Sep. 30, 2013 | Sep. 30, 2012 |
CONSOLIDATED STATEMENTS OF EARNINGS | ' | ' |
Net Sales | $2,675 | $2,549.50 |
Cost of Sales | 544.1 | 539.2 |
Gross Profit | 2,130.90 | 2,010.30 |
Operating expenses | ' | ' |
Selling, general and administrative | 1,680.20 | 1,527.90 |
Restructuring and other charges | 1.2 | 0.4 |
Total operating expenses | 1,681.40 | 1,528.30 |
Operating Income | 449.5 | 482 |
Interest expense, net | 13.5 | 15.8 |
Interest expense on debt extinguishment | ' | 19.1 |
Other income | ' | 1.8 |
Earnings before Income Taxes | 436 | 448.9 |
Provision for income taxes | 134.2 | 149.3 |
Net Earnings | 301.8 | 299.6 |
Net earnings attributable to noncontrolling interests | -1.1 | -0.1 |
Net Earnings Attributable to The Estee Lauder Companies Inc. | $300.70 | $299.50 |
Net earnings attributable to The Estee Lauder Companies Inc. per common share | ' | ' |
Basic (in dollars per share) | $0.78 | $0.77 |
Diluted (in dollars per share) | $0.76 | $0.76 |
Weighted-average common shares outstanding | ' | ' |
Basic (in shares) | 387.8 | 387.8 |
Diluted (in shares) | 394.9 | 395.5 |
Cash dividends declared per common share (in dollars per share) | $0.18 | ' |
CONSOLIDATED_STATEMENTS_OF_COM
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (USD $) | 3 Months Ended | |
In Millions, unless otherwise specified | Sep. 30, 2013 | Sep. 30, 2012 |
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) | ' | ' |
Net earnings | $301.80 | $299.60 |
Other comprehensive income (loss): | ' | ' |
Net unrealized investment gain (loss) | 0.3 | 0.1 |
Net derivative instrument gain (loss) | -17.5 | -15.9 |
Amounts included in net periodic benefit cost | 5.4 | 8.8 |
Translation adjustments | 67.7 | 72.1 |
Benefit (provision) for deferred income taxes on components of other comprehensive income | 5.9 | 4.3 |
Total other comprehensive income (loss) | 61.8 | 69.4 |
Comprehensive income (loss) | 363.6 | 369 |
Comprehensive (income) loss attributable to noncontrolling interests: | ' | ' |
Net earnings | -1.1 | -0.1 |
Translation adjustments | -0.6 | -0.9 |
Total comprehensive (income) loss attributable to noncontrolling interests | -1.7 | -1 |
Comprehensive income attributable to The Estee Lauder Companies Inc. | $361.90 | $368 |
CONSOLIDATED_BALANCE_SHEETS
CONSOLIDATED BALANCE SHEETS (USD $) | Sep. 30, 2013 | Jun. 30, 2013 |
In Millions, unless otherwise specified | ||
Current Assets | ' | ' |
Cash and cash equivalents | $1,322.20 | $1,495.70 |
Accounts receivable, net | 1,566.70 | 1,171.70 |
Inventory and promotional merchandise, net | 1,196.30 | 1,113.90 |
Prepaid expenses and other current assets | 547.2 | 515.9 |
Total current assets | 4,632.40 | 4,297.20 |
Property, Plant and Equipment, net | 1,364.40 | 1,350.70 |
Other Assets | ' | ' |
Goodwill | 885.4 | 881.5 |
Other intangible assets, net | 166.5 | 169.6 |
Other assets | 471.8 | 446.2 |
Total other assets | 1,523.70 | 1,497.30 |
Total assets | 7,520.50 | 7,145.20 |
Current Liabilities | ' | ' |
Current debt | 15.9 | 18.3 |
Accounts payable | 461.9 | 481.7 |
Other accrued liabilities | 1,509.80 | 1,434.60 |
Total current liabilities | 1,987.60 | 1,934.60 |
Noncurrent Liabilities | ' | ' |
Long-term debt | 1,324.70 | 1,326 |
Other noncurrent liabilities | 595.7 | 582.7 |
Total noncurrent liabilities | 1,920.40 | 1,908.70 |
Contingencies (Note 7) | ' | ' |
Equity | ' | ' |
Common stock, $.01 par value; Class A shares authorized: 1,300,000,000 at September 30, 2013 and June 30, 2013; shares issued: 409,045,607 at September 30, 2013 and 407,988,891 at June 30, 2013; Class B shares authorized: 304,000,000 at September 30, 2013 and June 30, 2013; shares issued and outstanding: 148,728,082 at September 30, 2013 and 148,978,082 at June 30, 2013 | 5.6 | 5.6 |
Paid-in capital | 2,365.90 | 2,289.90 |
Retained earnings | 5,594.70 | 5,364.10 |
Accumulated other comprehensive loss | -96.3 | -157.5 |
Stockholders' equity before treasury stock | 7,869.90 | 7,502.10 |
Less: Treasury stock, at cost; 169,834,647 Class A shares at September 30, 2013 and 168,972,698 Class A shares at June 30, 2013 | -4,274.10 | -4,215.20 |
Total stockholders' equity - The Estee Lauder Companies Inc. | 3,595.80 | 3,286.90 |
Noncontrolling interests | 16.7 | 15 |
Total equity | 3,612.50 | 3,301.90 |
Total liabilities and equity | $7,520.50 | $7,145.20 |
CONSOLIDATED_BALANCE_SHEETS_Pa
CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $) | Sep. 30, 2013 | Jun. 30, 2013 |
Common Class A | ' | ' |
Common stock, par value (in dollars per share) | $0.01 | $0.01 |
Common stock, shares authorized | 1,300,000,000 | 1,300,000,000 |
Common stock, shares issued | 409,045,607 | 407,988,891 |
Treasury stock, shares | 169,834,647 | 168,972,698 |
Common Class B | ' | ' |
Common stock, par value (in dollars per share) | $0.01 | $0.01 |
Common stock, shares authorized | 304,000,000 | 304,000,000 |
Common stock, shares issued | 148,728,082 | 148,978,082 |
Common stock, shares outstanding | 148,728,082 | 148,978,082 |
CONSOLIDATED_STATEMENTS_OF_CAS
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) | 3 Months Ended | |
In Millions, unless otherwise specified | Sep. 30, 2013 | Sep. 30, 2012 |
Cash Flows from Operating Activities | ' | ' |
Net earnings | $301.80 | $299.60 |
Adjustments to reconcile net earnings to net cash flows from operating activities: | ' | ' |
Depreciation and amortization | 88.9 | 77.5 |
Deferred income taxes | -23.4 | -18.8 |
Non-cash stock-based compensation | 56.3 | 54.5 |
Excess tax benefits from stock-based compensation arrangements | -9.8 | -15.6 |
Loss on disposal of property, plant and equipment | 2.3 | 4.5 |
Pension and post-retirement benefit expense | 17.4 | 20.9 |
Pension and post-retirement benefit contributions | -6.8 | -5.9 |
Other non-cash items | ' | -0.1 |
Changes in operating assets and liabilities: | ' | ' |
Increase in accounts receivable, net | -375.1 | -518.1 |
Increase in inventory and promotional merchandise, net | -58.1 | -59.2 |
Increase in other assets, net | -37.6 | -26.9 |
Decrease in accounts payable | -26.8 | -79.3 |
Increase in other liabilities | 100.8 | 141.7 |
Net cash flows provided by (used for) operating activities | 29.9 | -125.2 |
Cash Flows from Investing Activities | ' | ' |
Capital expenditures | -85.7 | -95.5 |
Acquisition of businesses and other intangible assets, net of cash acquired | -9.2 | -8.7 |
Net cash flows used for investing activities | -94.9 | -104.2 |
Cash Flows from Financing Activities | ' | ' |
Borrowings (repayments) of current debt, net | 0.2 | -195.4 |
Proceeds from issuance of long-term debt, net | ' | 498.7 |
Debt issuance costs | ' | -4.1 |
Repayments and redemptions of long-term debt | -3.7 | -235.9 |
Net proceeds from stock-based compensation transactions | 8.1 | 16.2 |
Excess tax benefits from stock-based compensation arrangements | 9.8 | 15.6 |
Payments to acquire treasury stock | -59.5 | -165.4 |
Dividends paid to stockholders | -69.8 | -0.5 |
Net cash flows used for financing activities | -114.9 | -70.8 |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | 6.4 | 6.2 |
Net Decrease in Cash and Cash Equivalents | -173.5 | -294 |
Cash and Cash Equivalents at Beginning of Period | 1,495.70 | 1,347.70 |
Cash and Cash Equivalents at End of Period | $1,322.20 | $1,053.70 |
SUMMARY_OF_SIGNIFICANT_ACCOUNT
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | 3 Months Ended | |||||||
Sep. 30, 2013 | ||||||||
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | ' | |||||||
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | ' | |||||||
NOTE 1 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | ||||||||
Basis of Presentation | ||||||||
The accompanying consolidated financial statements include the accounts of The Estée Lauder Companies Inc. and its subsidiaries (collectively, the “Company”). All significant intercompany balances and transactions have been eliminated. | ||||||||
Certain amounts in the consolidated financial statements of prior years have been reclassified to conform to current year presentation. | ||||||||
The unaudited interim consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments of a normal recurring nature considered necessary for a fair presentation have been included. The results of operations of any interim period are not necessarily indicative of the results of operations to be expected for the full fiscal year. For further information, refer to the consolidated financial statements and accompanying footnotes included in the Company’s Annual Report on Form 10-K for the year ended June 30, 2013. | ||||||||
Management Estimates | ||||||||
The preparation of financial statements and related disclosures in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses reported in those financial statements. Certain significant accounting policies that contain subjective management estimates and assumptions include those related to revenue recognition, inventory, pension and other post-retirement benefit costs, goodwill, other intangible assets and long-lived assets, and income taxes. Descriptions of these policies are discussed in the notes to consolidated financial statements in the Company’s Annual Report on Form 10-K for the year ended June 30, 2013. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, and makes adjustments when facts and circumstances dictate. As future events and their effects cannot be determined with precision, actual results could differ significantly from those estimates and assumptions. Significant changes, if any, in those estimates and assumptions resulting from continuing changes in the economic environment will be reflected in the consolidated financial statements in future periods. | ||||||||
Currency Translation and Transactions | ||||||||
All assets and liabilities of foreign subsidiaries and affiliates are translated at period-end rates of exchange, while revenue and expenses are translated at weighted-average rates of exchange for the period. Unrealized translation gains reported as cumulative translation adjustments through other comprehensive income (loss) (“OCI”) attributable to The Estée Lauder Companies Inc. amounted to $72.5 million and $76.5 million, net of tax, during the three months ended September 30, 2013 and 2012, respectively. For the Company’s Venezuelan subsidiary operating in a highly inflationary economy, the U.S. dollar is the functional currency. Remeasurement adjustments in financial statements in a highly inflationary economy and other transactional gains and losses are reflected in earnings. | ||||||||
The Company enters into foreign currency forward contracts and may enter into option contracts to hedge foreign currency transactions for periods consistent with its identified exposures. Accordingly, the Company categorizes these instruments as entered into for purposes other than trading. | ||||||||
The accompanying consolidated statements of earnings include net exchange gains on foreign currency transactions of $0.1 million and $0.9 million during the three months ended September 30, 2013 and 2012, respectively. | ||||||||
Accounts Receivable | ||||||||
Accounts receivable is stated net of the allowance for doubtful accounts and customer deductions totaling $23.5 million and $22.7 million as of September 30, 2013 and June 30, 2013, respectively. | ||||||||
Concentration of Credit Risk | ||||||||
The Company is a worldwide manufacturer, marketer and distributor of skin care, makeup, fragrance and hair care products. The Company’s sales are made primarily to department stores, perfumeries and specialty multi-brand retailers. The Company grants credit to all qualified customers and does not believe it is exposed significantly to any undue concentration of credit risk. | ||||||||
The Company’s largest customer sells products primarily within the United States and accounted for $341.6 million, or 13%, and $336.2 million, or 13%, of the Company’s consolidated net sales for the three months ended September 30, 2013 and 2012, respectively. This customer accounted for $251.6 million, or 16%, and $113.7 million, or 10%, of the Company’s accounts receivable at September 30, 2013 and June 30, 2013, respectively. | ||||||||
Inventory and Promotional Merchandise | ||||||||
Inventory and promotional merchandise, net consists of: | ||||||||
September 30 | June 30 | |||||||
(In millions) | 2013 | 2013 | ||||||
Raw materials | $ | 315.7 | $ | 274.2 | ||||
Work in process | 139.5 | 116.8 | ||||||
Finished goods | 568.8 | 510.9 | ||||||
Promotional merchandise | 172.3 | 212 | ||||||
$ | 1,196.30 | $ | 1,113.90 | |||||
Property, Plant and Equipment | ||||||||
September 30 | June 30 | |||||||
(In millions) | 2013 | 2013 | ||||||
Assets (Useful Life) | ||||||||
Land | $ | 14.9 | $ | 14.7 | ||||
Buildings and improvements (10 to 40 years) | 199.8 | 195.4 | ||||||
Machinery and equipment (3 to 10 years) | 665.4 | 647.9 | ||||||
Computer hardware and software (4 to 10 years) | 963.9 | 948.4 | ||||||
Furniture and fixtures (5 to 10 years) | 72.2 | 71.6 | ||||||
Leasehold improvements | 1,424.10 | 1,349.60 | ||||||
3,340.30 | 3,227.60 | |||||||
Less accumulated depreciation and amortization | 1,975.90 | 1,876.90 | ||||||
$ | 1,364.40 | $ | 1,350.70 | |||||
The cost of assets related to projects in progress of $163.8 million and $178.7 million as of September 30, 2013 and June 30, 2013, respectively, is included in their respective asset categories above. Depreciation and amortization of property, plant and equipment was $87.1 million and $75.3 million during the three months ended September 30, 2013 and 2012, respectively. Depreciation and amortization related to the Company’s manufacturing process is included in Cost of Sales and all other depreciation and amortization is included in Selling, general and administrative expenses in the accompanying consolidated statements of earnings. | ||||||||
Other Accrued Liabilities | ||||||||
Other accrued liabilities consist of the following: | ||||||||
September 30 | June 30 | |||||||
(In millions) | 2013 | 2013 | ||||||
Advertising, merchandising and sampling | $ | 377.2 | $ | 338.4 | ||||
Employee compensation | 328.7 | 433.3 | ||||||
Payroll and other taxes | 167.4 | 135.7 | ||||||
Accrued income taxes | 177.4 | 81.3 | ||||||
Other | 459.1 | 445.9 | ||||||
$ | 1,509.80 | $ | 1,434.60 | |||||
Income Taxes | ||||||||
The effective rate for income taxes was 30.8% and 33.3% for the three months ended September 30, 2013 and 2012, respectively. The decrease in the effective income tax rate was primarily attributable to income tax reserve adjustments and a lower effective tax rate on the Company’s foreign operations. | ||||||||
As of September 30, 2013 and June 30, 2013, the gross amount of unrecognized tax benefits, exclusive of interest and penalties, totaled $63.5 million and $64.0 million, respectively. The total amount of unrecognized tax benefits at September 30, 2013 that, if recognized, would affect the effective tax rate was $46.3 million. The total gross interest and penalties accrued related to unrecognized tax benefits during the three months ended September 30, 2013 in the accompanying consolidated statement of earnings was $0.3 million. The total gross accrued interest and penalties in the accompanying consolidated balance sheets at September 30, 2013 and June 30, 2013 was $17.7 million and $17.4 million, respectively. On the basis of the information available as of September 30, 2013, it is reasonably possible that the total amount of unrecognized tax benefits could decrease in a range of $10 million to $15 million within 12 months as a result of projected resolutions of global tax examinations and controversies and a potential lapse of the applicable statutes of limitations. | ||||||||
As of September 30, 2013 and June 30, 2013, the Company had current net deferred tax assets of $306.3 million and $296.0 million, respectively, substantially all of which are included in Prepaid expenses and other current assets in the accompanying consolidated balance sheets. In addition, the Company had noncurrent net deferred tax assets of $62.7 million and $50.3 million as of September 30, 2013 and June 30, 2013, respectively, substantially all of which are included in Other assets in the accompanying consolidated balance sheets. | ||||||||
Recently Adopted Accounting Standards | ||||||||
In February 2013, the Financial Accounting Standards Board (“FASB”) issued authoritative guidance requiring an entity to present, in a single location either parenthetically on the face of the financial statements or in a separate note, significant amounts reclassified from each component of accumulated other comprehensive income (loss) (“AOCI”) and the income statement line items affected by the reclassification. An entity is not permitted to provide this information parenthetically on the face of the income statement if it has items that are not required to be reclassified in their entirety to net income. Instead of disclosing the income statement line affected, a cross reference to other disclosures that provide additional details on these items is required. This guidance became effective prospectively for the Company’s fiscal 2014 first quarter and the adoption of this disclosure-only guidance did not have a significant impact on the Company’s consolidated financial statements. | ||||||||
In July 2012, the FASB amended its authoritative guidance related to testing indefinite-lived intangible assets for impairment. Under the revised guidance, entities testing their indefinite-lived intangible assets for impairment have the option of performing a qualitative assessment before performing further impairment testing. If entities determine, on the basis of qualitative factors, that it is more-likely-than-not that the asset is impaired, a quantitative test is required. This guidance became effective in the beginning of the Company’s fiscal 2014 and the adoption of this guidance did not have an impact on the Company’s consolidated financial statements. | ||||||||
In December 2011, the FASB issued authoritative guidance that creates new disclosure requirements about the nature of an entity’s rights of offset and related arrangements associated with its financial instruments and derivative instruments. This revised guidance helps reconcile differences in the offsetting requirements under U.S. GAAP and International Financial Reporting Standards (“IFRS”). These requirements mandate that entities disclose both gross and net information about instruments and transactions eligible for offset in the statement of financial position as well as instruments and transactions subject to an agreement similar to a master netting arrangement. In January 2013, the FASB issued an update that limits the scope of these disclosures to recognized derivative instruments, repurchase agreements and reverse repurchase agreements, and securities borrowing and lending transactions to the extent they are offset in the balance sheet or subject to an enforceable master netting arrangement or similar agreement. This disclosure-only guidance became effective for the Company’s fiscal 2014 first quarter, with retrospective application required. The Company currently does not hold any financial or derivative instruments within the scope of this guidance that are offset in its consolidated balance sheets or are subject to an enforceable master netting arrangement. The adoption of this guidance did not have an impact on the Company’s results of operations, financial position or cash flows. | ||||||||
Recently Issued Accounting Standards | ||||||||
In July 2013, the FASB issued authoritative guidance that requires an entity to present an unrecognized tax benefit, or a portion of an unrecognized tax benefit, in the financial statements as a reduction to a deferred tax asset for a net operating loss (“NOL”) carryforward, a similar tax loss, or a tax credit carryforward. If either (i) an NOL carryforward, a similar tax loss, or tax credit carryforward is not available as of the reporting date under the governing tax law to settle taxes that would result from the disallowance of the tax position or (ii) the entity does not intend to use the deferred tax asset for this purpose (provided that the tax law permits a choice), an entity should present an unrecognized tax benefit in the financial statements as a liability and should not net the unrecognized tax benefit with a deferred tax asset. This guidance becomes effective prospectively for unrecognized tax benefits that exist as of the Company’s fiscal 2015 first quarter, with retrospective application and early adoption permitted. The Company is currently evaluating the timing of adoption and the impact of this balance sheet presentation guidance but does not expect it to have a significant impact on the Company’s consolidated financial statements. | ||||||||
In March 2013, the FASB issued authoritative guidance to resolve the diversity in practice concerning the release of the cumulative translation adjustment (“CTA”) into net income (i) when a parent sells a part or all of its investment in a foreign entity or no longer holds a controlling financial interest in a subsidiary or group of assets within a foreign entity, and (ii) in connection with a step acquisition of a foreign entity. This amended guidance requires that CTA be released in net income only if the sale or transfer results in the complete or substantially complete liquidation of the foreign entity in which the subsidiary or group of assets had resided, and that a pro rata portion of the CTA be released into net income upon a partial sale of an equity method investment in a foreign entity only. In addition, the amended guidance clarifies the definition of a sale of an investment in a foreign entity to include both, events that result in the loss of a controlling financial interest in a foreign entity and events that result in an acquirer obtaining control of an acquiree in which it held an equity interest immediately prior to the date of acquisition. The CTA should be released into net income upon the occurrence of such events. This guidance becomes effective prospectively for the Company’s fiscal 2015 first quarter with early adoption permitted. The Company will apply this new guidance when it becomes effective, and the adoption of this guidance is not expected to have a significant impact on its consolidated financial statements. | ||||||||
In February 2013, the FASB issued authoritative guidance for the recognition, measurement, and disclosure of obligations resulting from joint and several liability arrangements for which the total amount of the obligations within the scope of this guidance is fixed at the reporting date. It does not apply to certain obligations that are addressed within existing guidance in U.S. GAAP. This guidance requires an entity to measure in-scope obligations with joint and several liability (e.g., debt arrangements, other contractual obligations, settled litigations, judicial rulings) as the sum of the amount the reporting entity agreed to pay on the basis of its arrangement among its co-obligors and any additional amount it expects to pay on behalf of its co-obligors. In addition, an entity is required to disclose the nature and amount of the obligation. This guidance should be applied retrospectively to all prior periods for those obligations resulting from joint and several liability arrangements within the scope of this guidance that exist at the beginning of the Company’s fiscal 2015 first quarter, with early adoption permitted. The Company will apply this guidance when it becomes effective, and the adoption of this guidance is not expected to have a significant impact on its consolidated financial statements. | ||||||||
GOODWILL_AND_OTHER_INTANGIBLE_
GOODWILL AND OTHER INTANGIBLE ASSETS | 3 Months Ended | |||||||||||||||||||
Sep. 30, 2013 | ||||||||||||||||||||
GOODWILL AND OTHER INTANGIBLE ASSETS | ' | |||||||||||||||||||
GOODWILL AND OTHER INTANGIBLE ASSETS | ' | |||||||||||||||||||
NOTE 2 — GOODWILL AND OTHER INTANGIBLE ASSETS | ||||||||||||||||||||
The following table presents goodwill by product category and the related change in the carrying amount: | ||||||||||||||||||||
(In millions) | Skin Care | Makeup | Fragrance | Hair Care | Total | |||||||||||||||
Balance as of June 30, 2013 | ||||||||||||||||||||
Goodwill | $ | 67.7 | $ | 430.4 | $ | 54.8 | $ | 401.6 | $ | 954.5 | ||||||||||
Accumulated impairments | (32.5 | ) | — | — | (40.5 | ) | (73.0 | ) | ||||||||||||
35.2 | 430.4 | 54.8 | 361.1 | 881.5 | ||||||||||||||||
Goodwill acquired during the period | — | 3 | — | — | 3 | |||||||||||||||
Translation and other adjustments | 0.1 | 0.1 | — | 0.7 | 0.9 | |||||||||||||||
0.1 | 3.1 | — | 0.7 | 3.9 | ||||||||||||||||
Balance as of September 30, 2013 | ||||||||||||||||||||
Goodwill | 68.7 | 433.5 | 54.8 | 402.9 | 959.9 | |||||||||||||||
Accumulated impairments | (33.4 | ) | — | — | (41.1 | ) | (74.5 | ) | ||||||||||||
$ | 35.3 | $ | 433.5 | $ | 54.8 | $ | 361.8 | $ | 885.4 | |||||||||||
Other intangible assets consist of the following: | ||||||||||||||||||||
September 30, 2013 | June 30, 2013 | |||||||||||||||||||
(In millions) | Gross | Accumulated | Total Net | Gross | Accumulated | Total Net | ||||||||||||||
Carrying | Amortization | Book | Carrying | Amortization | Book | |||||||||||||||
Value | Value | Value | Value | |||||||||||||||||
Amortizable intangible assets: | ||||||||||||||||||||
Customer lists and other | $ | 268.2 | $ | 207.4 | $ | 60.8 | $ | 268 | $ | 204.1 | $ | 63.9 | ||||||||
License agreements | 43 | 43 | — | 43 | 43 | — | ||||||||||||||
$ | 311.2 | $ | 250.4 | 60.8 | $ | 311 | $ | 247.1 | 63.9 | |||||||||||
Non-amortizable intangible assets: | ||||||||||||||||||||
Trademarks and other | 105.7 | 105.7 | ||||||||||||||||||
Total intangible assets | $ | 166.5 | $ | 169.6 | ||||||||||||||||
The aggregate amortization expense related to amortizable intangible assets was $3.2 million and $3.1 million for the three months ended September 30, 2013 and 2012, respectively. The estimated aggregate amortization expense for the remainder of fiscal 2014 and for each of fiscal 2015 to 2018 is $9.3 million, $12.1 million, $12.0 million, $9.9 million and $8.4 million, respectively. | ||||||||||||||||||||
RETURNS_AND_CHARGES_ASSOCIATED
RETURNS AND CHARGES ASSOCIATED WITH RESTRUCTURING ACTIVITIES | 3 Months Ended | ||||||||||||||||
Sep. 30, 2013 | |||||||||||||||||
RETURNS AND CHARGES ASSOCIATED WITH RESTRUCTURING ACTIVITIES | ' | ||||||||||||||||
RETURNS AND CHARGES ASSOCIATED WITH RESTRUCTURING ACTIVITIES | ' | ||||||||||||||||
NOTE 3 — RETURNS AND CHARGES ASSOCIATED WITH RESTRUCTURING ACTIVITIES | |||||||||||||||||
During the second quarter of fiscal 2013, the Company closed its multi-faceted costs savings program implemented in February 2009 (the “Program”) and will continue to execute all remaining initiatives through fiscal 2014. Total cumulative restructuring charges and other costs to implement those initiatives from inception of the Program to date are $321.6 million. For further information, refer to the consolidated financial statements and accompanying footnotes included in the Company’s Annual Report on Form 10-K for the year ended June 30, 2013. | |||||||||||||||||
Restructuring Charges | |||||||||||||||||
The following table presents aggregate restructuring charges related to the Program to date: | |||||||||||||||||
(In millions) | Employee- | Asset | Contract | Other Exit | Total | ||||||||||||
Related | Write-offs | Terminations | Costs | ||||||||||||||
Costs | |||||||||||||||||
Fiscal 2009 | $ | 60.9 | $ | 4.2 | $ | 3.4 | $ | 1.8 | $ | 70.3 | |||||||
Fiscal 2010 | 29.3 | 11 | 2.3 | 6.2 | 48.8 | ||||||||||||
Fiscal 2011 | 34.6 | 2.4 | 3 | 1.1 | 41.1 | ||||||||||||
Fiscal 2012 | 37.1 | 1.7 | 12.6 | 2.2 | 53.6 | ||||||||||||
Fiscal 2013 | 7.7 | 2.1 | 1.5 | 3.3 | 14.6 | ||||||||||||
Three months ended September 30, 2013 | 0.1 | — | 1.1 | — | 1.2 | ||||||||||||
Charges recorded through September 30, 2013 | $ | 169.7 | $ | 21.4 | $ | 23.9 | $ | 14.6 | $ | 229.6 | |||||||
The following table presents accrued restructuring charges and the related activities under the Program: | |||||||||||||||||
(In millions) | Employee- | Asset | Contract | Other Exit | Total | ||||||||||||
Related | Write-offs | Terminations | Costs | ||||||||||||||
Costs | |||||||||||||||||
Balance at June 30, 2013 | $ | 27.5 | $ | — | $ | 0.2 | $ | 0.7 | $ | 28.4 | |||||||
Charges | 0.1 | — | 1.1 | — | 1.2 | ||||||||||||
Cash payments | (5.7 | ) | — | (0.3 | ) | (0.3 | ) | (6.3 | ) | ||||||||
Translation adjustments | 0.1 | — | — | — | 0.1 | ||||||||||||
Balance at September 30, 2013 | $ | 22 | $ | — | $ | 1 | $ | 0.4 | $ | 23.4 | |||||||
Accrued restructuring charges at September 30, 2013 are expected to result in cash expenditures funded from cash provided by operations of approximately $17 million for the remainder of fiscal 2014 and $6 million in fiscal 2015. | |||||||||||||||||
DERIVATIVE_FINANCIAL_INSTRUMEN
DERIVATIVE FINANCIAL INSTRUMENTS | 3 Months Ended | |||||||||||||||||
Sep. 30, 2013 | ||||||||||||||||||
DERIVATIVE FINANCIAL INSTRUMENTS | ' | |||||||||||||||||
DERIVATIVE FINANCIAL INSTRUMENTS | ' | |||||||||||||||||
NOTE 4 — DERIVATIVE FINANCIAL INSTRUMENTS | ||||||||||||||||||
The Company addresses certain financial exposures through a controlled program of risk management that includes the use of derivative financial instruments. The Company enters into foreign currency forward contracts. The Company may enter into option contracts to reduce the effects of fluctuating foreign currency exchange rates and interest rate derivatives to manage the effects of interest rate movements on the Company’s aggregate liability portfolio. The Company also enters into foreign currency forward contracts and may use option contracts, not designated as hedging instruments, to mitigate the change in fair value of specific assets and liabilities on the balance sheet. The Company does not utilize derivative financial instruments for trading or speculative purposes. Costs associated with entering into these derivative financial instruments have not been material to the Company’s consolidated financial results. | ||||||||||||||||||
For each derivative contract entered into where the Company looks to obtain hedge accounting treatment, the Company formally documents all relationships between hedging instruments and hedged items, as well as its risk-management objective and strategy for undertaking the hedge transaction, the nature of the risk being hedged, how the hedging instruments’ effectiveness in offsetting the hedged risk will be assessed prospectively and retrospectively, and a description of the method of measuring ineffectiveness. This process includes linking all derivatives to specific assets and liabilities on the balance sheet or to specific firm commitments or forecasted transactions. The Company also formally assesses, both at the hedge’s inception and on an ongoing basis, whether the derivatives that are used in hedging transactions are highly effective in offsetting changes in fair values or cash flows of hedged items. If it is determined that a derivative is not highly effective, or that it has ceased to be a highly effective hedge, the Company will be required to discontinue hedge accounting with respect to that derivative prospectively. | ||||||||||||||||||
The fair values of the Company’s derivative financial instruments included in the consolidated balance sheets are presented as follows: | ||||||||||||||||||
Asset Derivatives | Liability Derivatives | |||||||||||||||||
Balance Sheet | Fair Value (1) | Balance Sheet | Fair Value (1) | |||||||||||||||
Location | Location | |||||||||||||||||
(In millions) | September 30 | June 30 | September 30 | June 30 | ||||||||||||||
2013 | 2013 | 2013 | 2013 | |||||||||||||||
Derivatives Designated as Hedging Instruments: | ||||||||||||||||||
Foreign currency forward contracts | Prepaid expenses and other current assets | $ | 8.1 | $ | 20.8 | Other accrued liabilities | $ | 11.5 | $ | 6.4 | ||||||||
Derivatives Not Designated as Hedging Instruments: | ||||||||||||||||||
Foreign currency forward contracts | Prepaid expenses and other current assets | 4.4 | 0.9 | Other accrued liabilities | 3.2 | 2.7 | ||||||||||||
Total Derivatives | $ | 12.5 | $ | 21.7 | $ | 14.7 | $ | 9.1 | ||||||||||
(1) See Note 5 — Fair Value Measurements for further information about how the fair value of derivative assets and liabilities are determined. | ||||||||||||||||||
The amounts of the gains and losses related to the Company’s derivative financial instruments designated as hedging instruments are presented as follows: | ||||||||||||||||||
Amount of Gain or (Loss) | Location of Gain or | Amount of Gain or (Loss) | ||||||||||||||||
Recognized in OCI on | (Loss) Reclassified | Reclassified from AOCI | ||||||||||||||||
Derivatives (Effective Portion) | from AOCI into | into Earnings | ||||||||||||||||
Earnings (Effective | (Effective Portion) (1) | |||||||||||||||||
Portion) | ||||||||||||||||||
Three Months Ended | Three Months Ended | |||||||||||||||||
September 30 | September 30 | |||||||||||||||||
(In millions) | 2013 | 2012 | 2013 | 2012 | ||||||||||||||
Derivatives in Cash Flow Hedging Relationships: | ||||||||||||||||||
Foreign currency forward contracts | $ | (13.6 | ) | $ | (13.5 | ) | Cost of sales | $ | 1.4 | $ | (0.1 | ) | ||||||
Selling, general and administrative | 2.4 | 2.5 | ||||||||||||||||
Total derivatives | $ | (13.6 | ) | $ | (13.5 | ) | $ | 3.8 | $ | 2.4 | ||||||||
(1) The amount of net loss recognized in earnings related to the amount excluded from effectiveness testing was $0.1 million for the three months ended September 30, 2013 and 2012. The net loss recognized in earnings related to the ineffective portion of the hedging relationships was $0.5 million for the three months ended September 30, 2013. There was no gain (loss) recognized in earnings related to the ineffective portion of the hedging relationships for the three months ended September 30, 2012. | ||||||||||||||||||
The amounts of the gains and losses related to the Company’s derivative financial instruments not designated as hedging instruments are presented as follows: | ||||||||||||||||||
Location of Gain or (Loss) | Amount of Gain or (Loss) | |||||||||||||||||
Recognized in Earnings on | Recognized in Earnings on | |||||||||||||||||
Derivatives | Derivatives | |||||||||||||||||
Three Months Ended | ||||||||||||||||||
September 30 | ||||||||||||||||||
(In millions) | 2013 | 2012 | ||||||||||||||||
Derivatives Not Designated as Hedging Instruments: | ||||||||||||||||||
Foreign currency forward contracts | Selling, general and administrative | $ | 3 | $ | 2.1 | |||||||||||||
Foreign Currency Cash-Flow Hedges | ||||||||||||||||||
The Company enters into foreign currency forward contracts to hedge anticipated transactions, as well as receivables and payables denominated in foreign currencies, for periods consistent with the Company’s identified exposures. The purpose of the hedging activities is to minimize the effect of foreign exchange rate movements on costs and on the cash flows that the Company receives from foreign subsidiaries. The majority of foreign currency forward contracts are denominated in currencies of major industrial countries. The Company may also enter into foreign currency option contracts to hedge anticipated transactions where there is a high probability that anticipated exposures will materialize. The foreign currency forward contracts entered into to hedge anticipated transactions have been designated as foreign currency cash-flow hedges and have varying maturities through the end of December 2015. Hedge effectiveness of foreign currency forward contracts is based on a hypothetical derivative methodology and excludes the portion of fair value attributable to the spot-forward difference which is recorded in current-period earnings. Hedge effectiveness of foreign currency option contracts is based on a dollar offset methodology. | ||||||||||||||||||
The ineffective portion of both foreign currency forward and option contracts is recorded in current-period earnings. For hedge contracts that are no longer deemed highly effective, hedge accounting is discontinued and gains and losses in AOCI are reclassified to earnings when the underlying forecasted transaction occurs. If it is probable that the forecasted transaction will no longer occur, then any gains or losses in AOCI are reclassified to current-period earnings. As of September 30, 2013, the Company’s foreign currency cash-flow hedges were highly effective in all material respects. The estimated net gain as of September 30, 2013 that is expected to be reclassified from AOCI into earnings, net of tax, within the next twelve months is $0.8 million. The accumulated gain (loss) on foreign currency cash-flow hedges in AOCI was $(0.5) million and $16.9 million as of September 30, 2013 and June 30, 2013, respectively. | ||||||||||||||||||
At September 30, 2013, the Company had foreign currency forward contracts in the amount of $1,763.6 million. The foreign currencies included in foreign currency forward contracts (notional value stated in U.S. dollars) are principally the British pound ($420.8 million), Euro ($360.6 million), Canadian dollar ($229.4 million), Australian dollar ($94.2 million), Swiss franc ($91.3 million), Hong Kong dollar ($90.5 million) and Japanese yen ($88.4 million). | ||||||||||||||||||
Credit Risk | ||||||||||||||||||
As a matter of policy, the Company only enters into derivative contracts with counterparties that have a long-term credit rating of at least A- or higher by at least two nationally recognized rating agencies. The counterparties to these contracts are major financial institutions. Exposure to credit risk in the event of nonperformance by any of the counterparties is limited to the gross fair value of contracts in asset positions, which totaled $12.5 million at September 30, 2013. To manage this risk, the Company has established strict counterparty credit guidelines that are continually monitored. Accordingly, management believes risk of loss under these hedging contracts is remote. | ||||||||||||||||||
Certain of the Company’s derivative financial instruments contain credit-risk-related contingent features. At September 30, 2013, the Company was in a net liability position for certain derivative contracts that contain such features with two counterparties. Such credit-risk-related contingent features would be triggered if (a) upon a merger involving the Company, the ratings of the surviving entity were materially weaker than prior to the merger or (b) the Company’s credit ratings fall below investment grade (rated below BBB-/Baa3) and the Company fails to enter into an International Swaps & Derivatives Association Credit Support Annex within 30 days of being requested by the counterparty. The fair value of collateral required to settle the instruments immediately if a triggering event were to occur is estimated at approximately the fair value of the contracts. The fair value of those contracts in a net liability position was approximately $0.8 million as of September 30, 2013 and the Company was in compliance with such credit-risk-related contingent features. | ||||||||||||||||||
FAIR_VALUE_MEASUREMENTS
FAIR VALUE MEASUREMENTS | 3 Months Ended | |||||||||||||
Sep. 30, 2013 | ||||||||||||||
FAIR VALUE MEASUREMENTS | ' | |||||||||||||
FAIR VALUE MEASUREMENTS | ' | |||||||||||||
NOTE 5 — FAIR VALUE MEASUREMENTS | ||||||||||||||
The Company records its financial assets and liabilities at fair value, which is defined as the price that would be received to sell an asset or paid to transfer a liability, in the principal or most advantageous market for the asset or liability, in an orderly transaction between market participants at the measurement date. The accounting for fair value measurements must be applied to nonfinancial assets and nonfinancial liabilities, which principally consist of assets and liabilities acquired through business combinations, goodwill, indefinite-lived intangible assets and long-lived assets for the purposes of calculating potential impairment, and liabilities associated with restructuring activities. The Company is required to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The three levels of inputs that may be used to measure fair value are as follows: | ||||||||||||||
Level 1: Inputs based on quoted market prices for identical assets or liabilities in active markets at the measurement date. | ||||||||||||||
Level 2: Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data. | ||||||||||||||
Level 3: Inputs reflect management’s best estimate of what market participants would use in pricing the asset or liability at the measurement date. The inputs are unobservable in the market and significant to the instrument’s valuation. | ||||||||||||||
The following table presents the Company’s hierarchy for its financial assets and liabilities measured at fair value on a recurring basis as of September 30, 2013: | ||||||||||||||
(In millions) | Level 1 | Level 2 | Level 3 | Total | ||||||||||
Assets: | ||||||||||||||
Foreign currency forward contracts | $ | — | $ | 12.5 | $ | — | $ | 12.5 | ||||||
Available-for-sale securities | 7 | — | — | 7 | ||||||||||
Total | $ | 7 | $ | 12.5 | $ | — | $ | 19.5 | ||||||
Liabilities: | ||||||||||||||
Foreign currency forward contracts | $ | — | $ | 14.7 | $ | — | $ | 14.7 | ||||||
The following table presents the Company’s hierarchy for its financial assets and liabilities measured at fair value on a recurring basis as of June 30, 2013: | ||||||||||||||
(In millions) | Level 1 | Level 2 | Level 3 | Total | ||||||||||
Assets: | ||||||||||||||
Foreign currency forward contracts | $ | — | $ | 21.7 | $ | — | $ | 21.7 | ||||||
Available-for-sale securities | 6.5 | — | — | 6.5 | ||||||||||
Total | $ | 6.5 | $ | 21.7 | $ | — | $ | 28.2 | ||||||
Liabilities: | ||||||||||||||
Foreign currency forward contracts | $ | — | $ | 9.1 | $ | — | $ | 9.1 | ||||||
The following methods and assumptions were used to estimate the fair value of the Company’s other classes of financial instruments for which it is practicable to estimate that value: | ||||||||||||||
Cash and cash equivalents — The carrying amount approximates fair value, primarily because of the short maturity of cash equivalent instruments. | ||||||||||||||
Available-for-sale securities — Available-for-sale securities are generally comprised of mutual funds and are valued using quoted market prices on an active exchange. Available-for-sale securities are included in Other assets in the accompanying consolidated balance sheets. | ||||||||||||||
Note receivable — During the second quarter of fiscal 2013, the Company amended the agreement related to the August 2007 sale of Rodan + Fields (a brand then owned by the Company) to receive a fixed amount in lieu of future contingent consideration and other rights. The fair value of the receivable under the amended agreement was determined by discounting the future cash flows using an implied market rate of 6.6%. This implied market rate reflects the Company’s estimate of interest rates prevailing in the market for notes with comparable remaining maturities, the creditworthiness of the counterparty, and an assessment of the ultimate collectability of the instrument. The implied market rate is deemed to be an unobservable input and as such the Company’s note receivable is classified within Level 3 of the valuation hierarchy. An increase or decrease in the risk premium of 100 basis points would not result in a significant change to the fair value of the receivable. | ||||||||||||||
Foreign currency forward contracts — The fair values of the Company’s foreign currency forward contracts were determined using an industry-standard valuation model, which is based on an income approach. The significant observable inputs to the model, such as swap yield curves and currency spot and forward rates, were obtained from an independent pricing service. To determine the fair value of contracts under the model, the difference between the contract price and the current forward rate was discounted using LIBOR for contracts with maturities up to 12 months, and swap yield curves for contracts with maturities greater than 12 months. | ||||||||||||||
Current and long-term debt — The fair value of the Company’s debt was estimated based on the current rates offered to the Company for debt with the same remaining maturities. To a lesser extent, debt also includes capital lease obligations for which the carrying amount approximates the fair value. The Company’s debt is classified within Level 2 of the valuation hierarchy. | ||||||||||||||
The estimated fair values of the Company’s financial instruments are as follows: | ||||||||||||||
September 30 | June 30 | |||||||||||||
2013 | 2013 | |||||||||||||
(In millions) | Carrying | Fair | Carrying | Fair | ||||||||||
Amount | Value | Amount | Value | |||||||||||
Nonderivatives | ||||||||||||||
Cash and cash equivalents | $ | 1,322.20 | $ | 1,322.20 | $ | 1,495.70 | $ | 1,495.70 | ||||||
Available-for-sale securities | 7 | 7 | 6.5 | 6.5 | ||||||||||
Note receivable | 16.8 | 16.9 | 16.8 | 16.9 | ||||||||||
Current and long-term debt | 1,340.60 | 1,377.40 | 1,344.30 | 1,387.80 | ||||||||||
Derivatives | ||||||||||||||
Foreign currency forward contracts — asset (liability) | (2.2 | ) | (2.2 | ) | 12.6 | 12.6 | ||||||||
PENSION_AND_POSTRETIREMENT_BEN
PENSION AND POST-RETIREMENT BENEFIT PLANS | 3 Months Ended | |||||||||||||||||||
Sep. 30, 2013 | ||||||||||||||||||||
PENSION AND POST-RETIREMENT BENEFIT PLANS | ' | |||||||||||||||||||
PENSION AND POST-RETIREMENT BENEFIT PLANS | ' | |||||||||||||||||||
NOTE 6 — PENSION AND POST-RETIREMENT BENEFIT PLANS | ||||||||||||||||||||
The Company maintains pension plans covering substantially all of its full-time employees for its U.S. operations and a majority of its international operations. The Company also maintains post-retirement benefit plans which provide certain medical and dental benefits to eligible employees. Descriptions of these plans are discussed in the notes to consolidated financial statements in the Company’s Annual Report on Form 10-K for the year ended June 30, 2013. | ||||||||||||||||||||
The components of net periodic benefit cost for the three months ended September 30, 2013 and 2012 consisted of the following: | ||||||||||||||||||||
Pension Plans | Other than | |||||||||||||||||||
Pension Plans | ||||||||||||||||||||
U.S. | International | Post-retirement | ||||||||||||||||||
(In millions) | 2013 | 2012 | 2013 | 2012 | 2013 | 2012 | ||||||||||||||
Service cost | $ | 7.9 | $ | 8.5 | $ | 6.1 | $ | 5.9 | $ | 0.9 | $ | 1.2 | ||||||||
Interest cost | 7.7 | 6.7 | 4.6 | 4.5 | 2 | 1.9 | ||||||||||||||
Expected return on plan assets | (11.7 | ) | (11.3 | ) | (5.0 | ) | (4.8 | ) | (0.5 | ) | (0.5 | ) | ||||||||
Amortization of: | ||||||||||||||||||||
Prior service cost | 0.2 | 0.1 | 0.7 | 0.7 | 0.2 | 0.2 | ||||||||||||||
Actuarial loss | 1.9 | 3.6 | 2.2 | 2.3 | 0.2 | 1.1 | ||||||||||||||
Settlements and curtailments | — | — | — | 0.8 | — | — | ||||||||||||||
Net periodic benefit cost | $ | 6 | $ | 7.6 | $ | 8.6 | $ | 9.4 | $ | 2.8 | $ | 3.9 | ||||||||
During the three months ended September 30, 2013, the Company made contributions to its international pension plans totaling approximately $4 million. | ||||||||||||||||||||
The amounts recognized in the consolidated balance sheets related to the Company’s pension and post-retirement benefit plans consist of the following: | ||||||||||||||||||||
September 30 | June 30 | |||||||||||||||||||
(In millions) | 2013 | 2013 | ||||||||||||||||||
Other assets | $ | 145.2 | $ | 144 | ||||||||||||||||
Other accrued liabilities | (23.2 | ) | (23.1 | ) | ||||||||||||||||
Other noncurrent liabilities | (358.4 | ) | (349.2 | ) | ||||||||||||||||
Funded status | (236.4 | ) | (228.3 | ) | ||||||||||||||||
Accumulated other comprehensive loss | 315 | 315 | ||||||||||||||||||
Net amount recognized | $ | 78.6 | $ | 86.7 | ||||||||||||||||
CONTINGENCIES
CONTINGENCIES | 3 Months Ended |
Sep. 30, 2013 | |
CONTINGENCIES | ' |
CONTINGENCIES | ' |
NOTE 7 — CONTINGENCIES | |
Legal Proceedings | |
The Company is involved, from time to time, in litigation and other legal proceedings incidental to its business. Management believes that the outcome of current litigation and legal proceedings will not have a material adverse effect upon the Company’s results of operations, financial condition or cash flows. However, management’s assessment of the Company’s current litigation and other legal proceedings could change in light of the discovery of facts with respect to legal actions or other proceedings pending against the Company, not presently known to the Company or determinations by judges, juries or other finders of fact which are not in accord with management’s evaluation of the possible liability or outcome of such litigation or proceedings. Except as disclosed below, reasonably possible losses in addition to the amounts accrued for litigation and other legal proceedings are not material to the Company’s consolidated financial statements. | |
During the fiscal 2007 fourth quarter, the former owner of the Darphin brand initiated litigation in the Paris Commercial Court against the Company and one of its subsidiaries seeking to recover €60.0 million ($81.2 million at the exchange rate at September 30, 2013) that he claims he was owed as additional consideration for the sale of Darphin to the Company in April 2003. On December 23, 2011, the Paris Commercial Court issued its judgment, awarding the former owner €22.9 million ($31.0 million at the exchange rate at September 30, 2013) plus interest from 2007. The Company has filed its appeal with the Paris Court of Appeal and oral arguments for the appeal are scheduled for June 2014. In accordance with the judgment, in January 2012, the Company paid €25.3 million ($34.2 million at the exchange rate at September 30, 2013) to the former owner and received from him a bank guarantee to assure repayment to the Company of such sum (or any part thereof) in the event that the judgment is reversed by the Paris Court of Appeal. Based upon its assessment of the case, as well as the advice of external counsel, the Company is maintaining the amount it previously accrued as an amount that it believes will ultimately be paid based on the probable outcome of the appeal. Such amount is less than the Paris Commercial Court’s award. | |
STOCKBASED_COMPENSATION
STOCK-BASED COMPENSATION | 3 Months Ended | |||||||||||
Sep. 30, 2013 | ||||||||||||
STOCK-BASED COMPENSATION | ' | |||||||||||
STOCK-BASED COMPENSATION | ' | |||||||||||
NOTE 8 — STOCK-BASED COMPENSATION | ||||||||||||
The Company has various stock-based compensation programs (the “Plans”) under which awards, including stock options, performance share units (“PSU”), restricted stock units (“RSU”), market share units (“MSU”), performance share units based on total stockholder return, and share units, may be granted. As of September 30, 2013, approximately 14,859,200 shares of the Company’s Class A Common Stock were reserved and available to be granted pursuant to these Plans. | ||||||||||||
Total net stock-based compensation expense is attributable to the granting of, and the remaining requisite service periods of stock options, PSUs, RSUs, MSUs, performance share units based on total stockholder return, and share units. Compensation expense attributable to net stock-based compensation is as follows: | ||||||||||||
Three Months Ended | ||||||||||||
September 30 | ||||||||||||
(In millions) | 2013 | 2012 | ||||||||||
Compensation expense | $ | 56.3 | $ | 54.5 | ||||||||
Income tax benefit | 18.3 | 17.6 | ||||||||||
As of September 30, 2013, the total unrecognized compensation cost related to unvested stock-based awards was $188.2 million and the related weighted-average period over which it is expected to be recognized is approximately 2 years. | ||||||||||||
Stock Options | ||||||||||||
The following is a summary of the Company’s stock option programs as of September 30, 2013 and changes during the three months then ended: | ||||||||||||
(Shares in thousands) | Shares | Weighted- | Aggregate | Weighted- | ||||||||
Average | Intrinsic | Average | ||||||||||
Exercise | Value (1) | Contractual Life | ||||||||||
Price Per | (in millions) | Remaining in | ||||||||||
Share | Years | |||||||||||
Outstanding at June 30, 2013 | 15,071.40 | $ | 36.6 | |||||||||
Granted at fair value | 1,805.60 | 67.31 | ||||||||||
Exercised | (298.5 | ) | 27.15 | |||||||||
Expired | (4.5 | ) | 24.35 | |||||||||
Forfeited | (37.5 | ) | 50.25 | |||||||||
Outstanding at September 30, 2013 | 16,536.50 | 40.09 | $ | 492.9 | 7.1 | |||||||
Vested and expected to vest at September 30, 2013 | 16,346.00 | 39.85 | $ | 491.3 | 7 | |||||||
Exercisable at September 30, 2013 | 8,286.20 | 26.77 | $ | 357.4 | 5.7 | |||||||
(1) The intrinsic value of a stock option is the amount by which the market value of the underlying stock exceeds the exercise price of the option. | ||||||||||||
The following is a summary of the per-share weighted-average grant date fair value of stock options granted and total intrinsic value of stock options exercised: | ||||||||||||
Three Months Ended | ||||||||||||
September 30 | ||||||||||||
(In millions, except per share data) | 2013 | 2012 | ||||||||||
Per-share weighted-average grant date fair value of stock options granted | $ | 23.03 | $ | 20.36 | ||||||||
Intrinsic value of stock options exercised | $ | 10.8 | $ | 27.3 | ||||||||
The fair value of each option grant was estimated on the date of grant using the Black-Scholes option-pricing model with the following assumptions: | ||||||||||||
Three Months Ended | ||||||||||||
September 30 | ||||||||||||
2013 | 2012 | |||||||||||
Weighted-average expected stock-price volatility | 33% | 34% | ||||||||||
Weighted-average expected option life | 7 years | 8 years | ||||||||||
Average risk-free interest rate | 2.50% | 1.20% | ||||||||||
Average dividend yield | 1.10% | 1.00% | ||||||||||
The Company uses a weighted-average expected stock-price volatility assumption that is a combination of both current and historical implied volatilities of the underlying stock. The implied volatilities were obtained from publicly available data sources. For the weighted-average expected option life assumption, the Company considers the exercise behavior of past grants and models the pattern of aggregate exercises. The average risk-free interest rate is based on the U.S. Treasury strip rate for the expected term of the options and the average dividend yield is based on historical experience. | ||||||||||||
Performance Share Units | ||||||||||||
During the three months ended September 30, 2013, the Company granted approximately 284,400 PSUs, which will be settled in stock subject to the achievement of the Company’s net sales, diluted net earnings per common share and return on invested capital goals for the three fiscal years ending June 30, 2016, all subject to continued employment or retirement of the grantees. PSUs granted in fiscal 2014 are accompanied by dividend equivalent rights that will be payable in cash upon settlement of the PSU. In September 2013, approximately 548,800 shares of the Company’s Class A Common Stock were issued and related accrued dividends were paid, relative to the target goals set at the time of issuance, in settlement of approximately 365,900 PSUs that vested as of June 30, 2013. | ||||||||||||
The following is a summary of the status of the Company’s PSUs as of September 30, 2013 and activity during the three months then ended: | ||||||||||||
Weighted-Average | ||||||||||||
Grant Date | ||||||||||||
(Shares in thousands) | Shares | Fair Value Per | ||||||||||
Share | ||||||||||||
Nonvested at June 30, 2013 | 510.9 | $ | 53.73 | |||||||||
Granted | 284.4 | 67.31 | ||||||||||
Vested | — | — | ||||||||||
Forfeited | — | — | ||||||||||
Nonvested at September 30, 2013 | 795.3 | 58.59 | ||||||||||
Restricted Stock Units | ||||||||||||
The Company granted approximately 1,281,000 RSUs during the three months ended September 30, 2013 which, at the time of grant, were scheduled to vest as follows: 469,300 in fiscal 2015, 480,900 in fiscal 2016, 327,800 in fiscal 2017 and 3,000 in fiscal 2018. All RSUs are subject to the continued employment or retirement of the grantees. Certain RSUs granted in fiscal 2014 are accompanied by dividend equivalent rights that will be payable in cash upon settlement of the RSU and, as such, were valued at the closing market value of the Company’s Class A Common Stock on the date of grant. Other RSUs granted in fiscal 2014 are not accompanied by dividend equivalent rights and, as such, were valued at the closing market value of the Company’s Class A Common Stock on the date of grant less the discounted present value of the dividends expected to be paid on the shares during the vesting period. | ||||||||||||
The following is a summary of the status of the Company’s RSUs as of September 30, 2013 and activity during the three months then ended: | ||||||||||||
Weighted-Average | ||||||||||||
Grant Date | ||||||||||||
(Shares in thousands) | Shares | Fair Value Per | ||||||||||
Share | ||||||||||||
Nonvested at June 30, 2013 | 2,222.80 | $ | 52.68 | |||||||||
Granted | 1,281.00 | 65.97 | ||||||||||
Vested | — | — | ||||||||||
Forfeited | (23.1 | ) | 55.27 | |||||||||
Nonvested at September 30, 2013 | 3,480.70 | 57.55 | ||||||||||
Performance Share Units Based on Total Stockholder Return | ||||||||||||
During fiscal 2013, the Company granted PSUs to an executive of the Company with an aggregate target payout of 162,760 shares of the Company’s Class A Common Stock, subject to continued employment through the end of the relative performance periods, which end June 30, 2015, 2016 and 2017. Such PSUs will be settled based upon the Company’s relative total stockholder return (“TSR”) over the relevant performance period as compared to companies in the S&P 500 on July 1, 2012. No settlement will occur if the Company’s TSR falls below a minimum threshold, and up to an aggregate of 260,416 shares of the Company’s Class A Common Stock will be issued depending on the extent to which the Company’s TSR equals or exceeds the minimum threshold. The PSUs are accompanied by dividend equivalent rights that will be payable in cash upon settlement of the PSUs. | ||||||||||||
The grant date fair value of the PSUs of $11.0 million was estimated using a lattice model with a Monte Carlo simulation and the following assumptions for each performance period, respectively: contractual life of 33, 45 and 57 months, average risk-free interest rate of 0.3%, 0.5% and 0.7% and a dividend yield of 1.0%. Using the historical stock prices and dividends from public sources, the Company estimated the covariance structure of the returns on S&P 500 stocks. The volatility for the Company’s stock produced by this estimation was 32%. The average risk-free interest rate is based on the U.S. Treasury strip rates over the contractual term of the grant and the dividend yield is based on historical experience. | ||||||||||||
Market Share Unit | ||||||||||||
As of September 30, 2013, the Company had one outstanding market share unit with a grant date fair value of $10.6 million that was estimated using a lattice model with a Monte Carlo simulation and the following assumptions: contractual life of 41 months, a weighted-average expected volatility of 29%, a weighted-average risk-free interest rate of 1.6% and a weighted-average dividend yield of 1.0%. The Company used an expected stock-price volatility assumption that is a combination of both current and historical implied volatilities from options on the underlying stock. The implied volatilities were obtained from publicly available data sources. The expected life is equal to the contractual term of the grant. The average risk-free interest rate is based on the U.S. Treasury strip rates over the contractual term of the grant and the average dividend yield is based on historical experience. | ||||||||||||
Share Units | ||||||||||||
The Company grants share units to certain non-employee directors under the Non-Employee Director Share Incentive Plan. The following is a summary of the status of the Company’s share units as of September 30, 2013 and activity during the three months then ended: | ||||||||||||
Weighted-Average | ||||||||||||
Grant Date | ||||||||||||
(Shares in thousands) | Shares | Fair Value Per | ||||||||||
Share | ||||||||||||
Outstanding at June 30, 2013 | 87.3 | $ | 33.27 | |||||||||
Granted | — | — | ||||||||||
Dividend equivalents | 0.2 | 71.11 | ||||||||||
Converted | — | — | ||||||||||
Outstanding at September 30, 2013 | 87.5 | 33.36 | ||||||||||
Cash Units | ||||||||||||
Certain non-employee directors defer cash compensation in the form of cash payout share units, which are not subject to the Plans. These share units are classified as liabilities and, as such, their fair value is adjusted to reflect the current market value of the Company’s Class A Common Stock. The Company recorded $1.0 million and $1.6 million as compensation expense to reflect additional deferrals and the change in the market value for the three months ended September 30, 2013 and 2012, respectively. | ||||||||||||
NET_EARNINGS_ATTRIBUTABLE_TO_T
NET EARNINGS ATTRIBUTABLE TO THE ESTEE LAUDER COMPANIES INC. PER COMMON SHARE | 3 Months Ended | |||||||
Sep. 30, 2013 | ||||||||
NET EARNINGS ATTRIBUTABLE TO THE ESTEE LAUDER COMPANIES INC. PER COMMON SHARE | ' | |||||||
NET EARNINGS ATTRIBUTABLE TO THE ESTEE LAUDER COMPANIES INC. PER COMMON SHARE | ' | |||||||
NOTE 9 — NET EARNINGS ATTRIBUTABLE TO THE ESTÉE LAUDER COMPANIES INC. PER COMMON SHARE | ||||||||
Net earnings attributable to The Estée Lauder Companies Inc. per common share (“basic EPS”) is computed by dividing net earnings attributable to The Estée Lauder Companies Inc. by the weighted-average number of common shares outstanding and contingently issuable shares (which satisfy certain conditions). Net earnings attributable to The Estée Lauder Companies Inc. per common share assuming dilution (“diluted EPS”) is computed by reflecting potential dilution from stock-based awards. | ||||||||
A reconciliation between the numerators and denominators of the basic and diluted EPS computations is as follows: | ||||||||
Three Months Ended | ||||||||
September 30 | ||||||||
(In millions, except per share data) | 2013 | 2012 | ||||||
Numerator: | ||||||||
Net earnings attributable to The Estée Lauder Companies Inc. | $ | 300.7 | $ | 299.5 | ||||
Denominator: | ||||||||
Weighted-average common shares outstanding — Basic | 387.8 | 387.8 | ||||||
Effect of dilutive stock options | 5.1 | 5.7 | ||||||
Effect of RSUs | 1.6 | 1.7 | ||||||
Effect of PSUs based on TSR | 0.1 | — | ||||||
Effect of MSU | 0.3 | 0.3 | ||||||
Weighted-average common shares outstanding — Diluted | 394.9 | 395.5 | ||||||
Net earnings attributable to The Estée Lauder Companies Inc. per common share: | ||||||||
Basic | $ | 0.78 | $ | 0.77 | ||||
Diluted | 0.76 | 0.76 | ||||||
As of September 30, 2013 and 2012, outstanding options to purchase 1.9 million and 3.2 million shares, respectively, of Class A Common Stock were not included in the computation of diluted EPS because their inclusion would be anti-dilutive. As of September 30, 2013 and 2012, 0.8 million and 0.9 million of PSUs, respectively, have been excluded from the calculation of diluted EPS because the number of shares ultimately issued is contingent on the achievement of certain performance targets of the Company, as discussed in Note 8 — Stock-Based Compensation. | ||||||||
EQUITY
EQUITY | 3 Months Ended | |||||||||||||||||||||||||
Sep. 30, 2013 | ||||||||||||||||||||||||||
EQUITY | ' | |||||||||||||||||||||||||
EQUITY | ' | |||||||||||||||||||||||||
NOTE 10 — EQUITY | ||||||||||||||||||||||||||
Total Stockholders’ Equity — The Estée Lauder Companies Inc. | Non- | |||||||||||||||||||||||||
(In millions) | Common | Paid-in | Retained | AOCI | Treasury | Total | controlling | Total | ||||||||||||||||||
Stock | Capital | Earnings | Stock | Interests | Equity | |||||||||||||||||||||
Balance at June 30, 2013 | $ | 5.6 | $ | 2,289.90 | $ | 5,364.10 | $ | (157.5 | ) | $ | (4,215.2 | ) | $ | 3,286.90 | $ | 15 | $ | 3,301.90 | ||||||||
Net earnings | — | — | 300.7 | — | — | 300.7 | 1.1 | 301.8 | ||||||||||||||||||
Common stock dividends - cash | — | — | (70.1 | ) | — | — | (70.1 | ) | — | (70.1 | ) | |||||||||||||||
Other comprehensive income | — | — | — | 61.2 | — | 61.2 | 0.6 | 61.8 | ||||||||||||||||||
Acquisition of treasury stock | — | — | — | — | (41.8 | ) | (41.8 | ) | — | (41.8 | ) | |||||||||||||||
Stock-based compensation | — | 76 | — | — | (17.1 | ) | 58.9 | — | 58.9 | |||||||||||||||||
Balance at September 30, 2013 | $ | 5.6 | $ | 2,365.90 | $ | 5,594.70 | $ | (96.3 | ) | $ | (4,274.1 | ) | $ | 3,595.80 | $ | 16.7 | $ | 3,612.50 | ||||||||
The following is a summary of quarterly cash dividends declared per share on the Company’s Class A and Class B Common Stock during the three months ended September 30, 2013: | ||||||||||||||||||||||||||
Date Declared | Record Date | Payable Date | Amount per Share | |||||||||||||||||||||||
August 14, 2013 | August 30, 2013 | September 16, 2013 | $ | 0.18 | ||||||||||||||||||||||
On October 30, 2013, a quarterly dividend was declared in the amount of $.20 per share on the Company’s Class A and Class B Common Stock. The dividend is payable in cash on December 16, 2013 to stockholders of record at the close of business on November 29, 2013. | ||||||||||||||||||||||||||
Common Stock | ||||||||||||||||||||||||||
During the three months ended September 30, 2013, the Company purchased approximately 0.9 million shares of its Class A Common Stock for $59.5 million. | ||||||||||||||||||||||||||
During the three months ended September 30, 2013, approximately 0.3 million shares of the Company’s Class B Common Stock were converted into the Company’s Class A Common Stock. | ||||||||||||||||||||||||||
Accumulated Other Comprehensive Income (Loss) | ||||||||||||||||||||||||||
The following table represents changes in AOCI, net of tax, by component for the three months ended September 30, 2013: | ||||||||||||||||||||||||||
(In millions) | Net | Net | Amounts | Translation | Total | |||||||||||||||||||||
Unrealized | Derivative | Included in | Adjustments | |||||||||||||||||||||||
Investment | Instrument | Net Periodic | ||||||||||||||||||||||||
Gain (Loss) | Gain (Loss) | Benefit Cost | ||||||||||||||||||||||||
Balance at June 30, 2013 | $ | 0.8 | $ | 18.3 | $ | (213.7 | ) | $ | 37.1 | $ | (157.5 | ) | ||||||||||||||
OCI before reclassifications | 0.2 | (8.7 | ) | (4.1 | )(1) | 72.5 | 59.9 | |||||||||||||||||||
Amounts reclassified from AOCI | — | (2.5 | ) | 3.8 | — | 1.3 | ||||||||||||||||||||
Net current-period OCI | 0.2 | (11.2 | ) | (0.3 | ) | 72.5 | 61.2 | |||||||||||||||||||
Balance at September 30, 2013 | $ | 1 | $ | 7.1 | $ | (214.0 | ) | $ | 109.6 | $ | (96.3 | ) | ||||||||||||||
(1) Includes foreign currency translation losses of $5.4 million. | ||||||||||||||||||||||||||
The following table represents the effects of reclassification adjustments from AOCI into net earnings for the three months ended September 30, 2013: | ||||||||||||||||||||||||||
Amount Reclassified | ||||||||||||||||||||||||||
from AOCI | ||||||||||||||||||||||||||
(In millions) | Three Months Ended | Affected Line Item in Consolidated | ||||||||||||||||||||||||
September 30, 2013 | Statement of Earnings | |||||||||||||||||||||||||
Gain (Loss) on Cash-Flow Hedges | ||||||||||||||||||||||||||
Foreign currency forward contracts | $ | 1.4 | Cost of sales | |||||||||||||||||||||||
Foreign currency forward contracts | 2.4 | Selling, general and administrative | ||||||||||||||||||||||||
3.8 | Earnings before income taxes | |||||||||||||||||||||||||
Benefit (provision) for deferred taxes | (1.4 | ) | Provision for income taxes | |||||||||||||||||||||||
$ | 2.4 | Net earnings | ||||||||||||||||||||||||
Gain (Loss) on Fair-Value Hedges | ||||||||||||||||||||||||||
Settled interest rate-related derivatives | $ | 0.1 | Interest expense, net | |||||||||||||||||||||||
Benefit (provision) for deferred taxes | — | Provision for income taxes | ||||||||||||||||||||||||
$ | 0.1 | Net earnings | ||||||||||||||||||||||||
Amounts Included in Net Periodic Benefit Cost | ||||||||||||||||||||||||||
Amortization of prior service cost | $ | (1.1 | ) | -1 | ||||||||||||||||||||||
Amortization of actuarial loss | (4.3 | ) | -1 | |||||||||||||||||||||||
(5.4 | ) | Earnings before income taxes | ||||||||||||||||||||||||
Benefit (provision) for deferred taxes | 1.6 | Provision for income taxes | ||||||||||||||||||||||||
$ | (3.8 | ) | Net earnings | |||||||||||||||||||||||
Total reclassification adjustments, net | $ | (1.3 | ) | Net earnings | ||||||||||||||||||||||
(1) See Note 6 — Pension and Post-Retirement Benefit Plans for additional information. | ||||||||||||||||||||||||||
STATEMENT_OF_CASH_FLOWS
STATEMENT OF CASH FLOWS | 3 Months Ended | |||||||
Sep. 30, 2013 | ||||||||
STATEMENT OF CASH FLOWS | ' | |||||||
STATEMENT OF CASH FLOWS | ' | |||||||
NOTE 11 — STATEMENT OF CASH FLOWS | ||||||||
Supplemental cash flow information for the three months ended September 30, 2013 and 2012 is as follows: | ||||||||
(In millions) | 2013 | 2012 | ||||||
Cash: | ||||||||
Cash paid during the period for interest | $ | 8.7 | $ | 27.5 | ||||
Cash paid during the period for income taxes | $ | 50.8 | $ | 67.3 | ||||
Non-cash investing and financing activities: | ||||||||
Incremental tax benefit from the exercise of stock options | $ | (0.8 | ) | $ | (1.8 | ) | ||
Capital lease obligations incurred | $ | 1.7 | $ | 0.6 | ||||
SEGMENT_DATA_AND_RELATED_INFOR
SEGMENT DATA AND RELATED INFORMATION | 3 Months Ended | |||||||
Sep. 30, 2013 | ||||||||
SEGMENT DATA AND RELATED INFORMATION | ' | |||||||
SEGMENT DATA AND RELATED INFORMATION | ' | |||||||
NOTE 12 — SEGMENT DATA AND RELATED INFORMATION | ||||||||
Reportable operating segments include components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker (the “Chief Executive”) in deciding how to allocate resources and in assessing performance. Although the Company operates in one business segment, beauty products, management also evaluates performance on a product category basis. Product category performance is measured based upon net sales before returns associated with restructuring activities, and earnings before income taxes, net interest expense, interest expense on debt extinguishment, other income and total charges associated with restructuring activities. Returns and charges associated with restructuring activities are not allocated to the product categories because they result from activities that are deemed part of a company-wide program to redesign the Company’s organizational structure. | ||||||||
The accounting policies for the Company’s reportable segments are substantially the same as those for the consolidated financial statements, as described in the notes to consolidated financial statements in the Company’s Annual Report on Form 10-K for the year ended June 30, 2013. The assets and liabilities of the Company are managed centrally and are reported internally in the same manner as the consolidated financial statements; thus, no additional information is produced for the Chief Executive or included herein. There has been no significant variance in the total or long-lived asset values associated with the Company’s segment data since June 30, 2013. | ||||||||
Three Months Ended | ||||||||
September 30 | ||||||||
(In millions) | 2013 | 2012 | ||||||
PRODUCT CATEGORY DATA | ||||||||
Net Sales: | ||||||||
Skin Care | $ | 1,171.00 | $ | 1,113.50 | ||||
Makeup | 1,001.00 | 960.4 | ||||||
Fragrance | 367.4 | 347.6 | ||||||
Hair Care | 124.8 | 113.9 | ||||||
Other | 10.8 | 14.1 | ||||||
Net Sales | $ | 2,675.00 | $ | 2,549.50 | ||||
Operating Income (Loss) before total charges associated with restructuring activities: | ||||||||
Skin Care | $ | 241.6 | $ | 259 | ||||
Makeup | 166.3 | 161.3 | ||||||
Fragrance | 36.9 | 53.4 | ||||||
Hair Care | 8.4 | 10.7 | ||||||
Other | (2.5 | ) | (2.0 | ) | ||||
450.7 | 482.4 | |||||||
Reconciliation: | ||||||||
Total charges associated with restructuring activities | (1.2 | ) | (0.4 | ) | ||||
Interest expense, net | (13.5 | ) | (15.8 | ) | ||||
Interest expense on debt extinguishment | — | (19.1 | ) | |||||
Other income | — | 1.8 | ||||||
Earnings before income taxes | $ | 436 | $ | 448.9 | ||||
GEOGRAPHIC DATA | ||||||||
Net Sales: | ||||||||
The Americas | $ | 1,202.40 | $ | 1,182.10 | ||||
Europe, the Middle East & Africa | 891.2 | 824.9 | ||||||
Asia/Pacific | 581.4 | 542.5 | ||||||
Net Sales | $ | 2,675.00 | $ | 2,549.50 | ||||
Operating Income (Loss): | ||||||||
The Americas | $ | 156 | $ | 172.3 | ||||
Europe, the Middle East & Africa | 180.8 | 196.9 | ||||||
Asia/Pacific | 113.9 | 113.2 | ||||||
450.7 | 482.4 | |||||||
Total charges associated with restructuring activities | (1.2 | ) | (0.4 | ) | ||||
Operating Income | $ | 449.5 | $ | 482 | ||||
SUMMARY_OF_SIGNIFICANT_ACCOUNT1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) | 3 Months Ended | |||||||
Sep. 30, 2013 | ||||||||
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | ' | |||||||
Basis of Presentation | ' | |||||||
Basis of Presentation | ||||||||
The accompanying consolidated financial statements include the accounts of The Estée Lauder Companies Inc. and its subsidiaries (collectively, the “Company”). All significant intercompany balances and transactions have been eliminated. | ||||||||
Certain amounts in the consolidated financial statements of prior years have been reclassified to conform to current year presentation. | ||||||||
The unaudited interim consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments of a normal recurring nature considered necessary for a fair presentation have been included. The results of operations of any interim period are not necessarily indicative of the results of operations to be expected for the full fiscal year. For further information, refer to the consolidated financial statements and accompanying footnotes included in the Company’s Annual Report on Form 10-K for the year ended June 30, 2013. | ||||||||
Management Estimates | ' | |||||||
Management Estimates | ||||||||
The preparation of financial statements and related disclosures in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses reported in those financial statements. Certain significant accounting policies that contain subjective management estimates and assumptions include those related to revenue recognition, inventory, pension and other post-retirement benefit costs, goodwill, other intangible assets and long-lived assets, and income taxes. Descriptions of these policies are discussed in the notes to consolidated financial statements in the Company’s Annual Report on Form 10-K for the year ended June 30, 2013. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, and makes adjustments when facts and circumstances dictate. As future events and their effects cannot be determined with precision, actual results could differ significantly from those estimates and assumptions. Significant changes, if any, in those estimates and assumptions resulting from continuing changes in the economic environment will be reflected in the consolidated financial statements in future periods. | ||||||||
Currency Translation and Transactions | ' | |||||||
Currency Translation and Transactions | ||||||||
All assets and liabilities of foreign subsidiaries and affiliates are translated at period-end rates of exchange, while revenue and expenses are translated at weighted-average rates of exchange for the period. Unrealized translation gains reported as cumulative translation adjustments through other comprehensive income (loss) (“OCI”) attributable to The Estée Lauder Companies Inc. amounted to $72.5 million and $76.5 million, net of tax, during the three months ended September 30, 2013 and 2012, respectively. For the Company’s Venezuelan subsidiary operating in a highly inflationary economy, the U.S. dollar is the functional currency. Remeasurement adjustments in financial statements in a highly inflationary economy and other transactional gains and losses are reflected in earnings. | ||||||||
The Company enters into foreign currency forward contracts and may enter into option contracts to hedge foreign currency transactions for periods consistent with its identified exposures. Accordingly, the Company categorizes these instruments as entered into for purposes other than trading. | ||||||||
The accompanying consolidated statements of earnings include net exchange gains on foreign currency transactions of $0.1 million and $0.9 million during the three months ended September 30, 2013 and 2012, respectively. | ||||||||
Accounts Receivable | ' | |||||||
Accounts Receivable | ||||||||
Accounts receivable is stated net of the allowance for doubtful accounts and customer deductions totaling $23.5 million and $22.7 million as of September 30, 2013 and June 30, 2013, respectively. | ||||||||
Concentration of Credit Risk | ' | |||||||
Concentration of Credit Risk | ||||||||
The Company is a worldwide manufacturer, marketer and distributor of skin care, makeup, fragrance and hair care products. The Company’s sales are made primarily to department stores, perfumeries and specialty multi-brand retailers. The Company grants credit to all qualified customers and does not believe it is exposed significantly to any undue concentration of credit risk. | ||||||||
The Company’s largest customer sells products primarily within the United States and accounted for $341.6 million, or 13%, and $336.2 million, or 13%, of the Company’s consolidated net sales for the three months ended September 30, 2013 and 2012, respectively. This customer accounted for $251.6 million, or 16%, and $113.7 million, or 10%, of the Company’s accounts receivable at September 30, 2013 and June 30, 2013, respectively. | ||||||||
Property, Plant and Equipment | ' | |||||||
Property, Plant and Equipment | ||||||||
September 30 | June 30 | |||||||
(In millions) | 2013 | 2013 | ||||||
Assets (Useful Life) | ||||||||
Land | $ | 14.9 | $ | 14.7 | ||||
Buildings and improvements (10 to 40 years) | 199.8 | 195.4 | ||||||
Machinery and equipment (3 to 10 years) | 665.4 | 647.9 | ||||||
Computer hardware and software (4 to 10 years) | 963.9 | 948.4 | ||||||
Furniture and fixtures (5 to 10 years) | 72.2 | 71.6 | ||||||
Leasehold improvements | 1,424.10 | 1,349.60 | ||||||
3,340.30 | 3,227.60 | |||||||
Less accumulated depreciation and amortization | 1,975.90 | 1,876.90 | ||||||
$ | 1,364.40 | $ | 1,350.70 | |||||
The cost of assets related to projects in progress of $163.8 million and $178.7 million as of September 30, 2013 and June 30, 2013, respectively, is included in their respective asset categories above. Depreciation and amortization of property, plant and equipment was $87.1 million and $75.3 million during the three months ended September 30, 2013 and 2012, respectively. Depreciation and amortization related to the Company’s manufacturing process is included in Cost of Sales and all other depreciation and amortization is included in Selling, general and administrative expenses in the accompanying consolidated statements of earnings. | ||||||||
Income Taxes | ' | |||||||
Income Taxes | ||||||||
The effective rate for income taxes was 30.8% and 33.3% for the three months ended September 30, 2013 and 2012, respectively. The decrease in the effective income tax rate was primarily attributable to income tax reserve adjustments and a lower effective tax rate on the Company’s foreign operations. | ||||||||
As of September 30, 2013 and June 30, 2013, the gross amount of unrecognized tax benefits, exclusive of interest and penalties, totaled $63.5 million and $64.0 million, respectively. The total amount of unrecognized tax benefits at September 30, 2013 that, if recognized, would affect the effective tax rate was $46.3 million. The total gross interest and penalties accrued related to unrecognized tax benefits during the three months ended September 30, 2013 in the accompanying consolidated statement of earnings was $0.3 million. The total gross accrued interest and penalties in the accompanying consolidated balance sheets at September 30, 2013 and June 30, 2013 was $17.7 million and $17.4 million, respectively. On the basis of the information available as of September 30, 2013, it is reasonably possible that the total amount of unrecognized tax benefits could decrease in a range of $10 million to $15 million within 12 months as a result of projected resolutions of global tax examinations and controversies and a potential lapse of the applicable statutes of limitations. | ||||||||
As of September 30, 2013 and June 30, 2013, the Company had current net deferred tax assets of $306.3 million and $296.0 million, respectively, substantially all of which are included in Prepaid expenses and other current assets in the accompanying consolidated balance sheets. In addition, the Company had noncurrent net deferred tax assets of $62.7 million and $50.3 million as of September 30, 2013 and June 30, 2013, respectively, substantially all of which are included in Other assets in the accompanying consolidated balance sheets. | ||||||||
Recently Adopted and Issued Accounting Standards | ' | |||||||
Recently Adopted Accounting Standards | ||||||||
In February 2013, the Financial Accounting Standards Board (“FASB”) issued authoritative guidance requiring an entity to present, in a single location either parenthetically on the face of the financial statements or in a separate note, significant amounts reclassified from each component of accumulated other comprehensive income (loss) (“AOCI”) and the income statement line items affected by the reclassification. An entity is not permitted to provide this information parenthetically on the face of the income statement if it has items that are not required to be reclassified in their entirety to net income. Instead of disclosing the income statement line affected, a cross reference to other disclosures that provide additional details on these items is required. This guidance became effective prospectively for the Company’s fiscal 2014 first quarter and the adoption of this disclosure-only guidance did not have a significant impact on the Company’s consolidated financial statements. | ||||||||
In July 2012, the FASB amended its authoritative guidance related to testing indefinite-lived intangible assets for impairment. Under the revised guidance, entities testing their indefinite-lived intangible assets for impairment have the option of performing a qualitative assessment before performing further impairment testing. If entities determine, on the basis of qualitative factors, that it is more-likely-than-not that the asset is impaired, a quantitative test is required. This guidance became effective in the beginning of the Company’s fiscal 2014 and the adoption of this guidance did not have an impact on the Company’s consolidated financial statements. | ||||||||
In December 2011, the FASB issued authoritative guidance that creates new disclosure requirements about the nature of an entity’s rights of offset and related arrangements associated with its financial instruments and derivative instruments. This revised guidance helps reconcile differences in the offsetting requirements under U.S. GAAP and International Financial Reporting Standards (“IFRS”). These requirements mandate that entities disclose both gross and net information about instruments and transactions eligible for offset in the statement of financial position as well as instruments and transactions subject to an agreement similar to a master netting arrangement. In January 2013, the FASB issued an update that limits the scope of these disclosures to recognized derivative instruments, repurchase agreements and reverse repurchase agreements, and securities borrowing and lending transactions to the extent they are offset in the balance sheet or subject to an enforceable master netting arrangement or similar agreement. This disclosure-only guidance became effective for the Company’s fiscal 2014 first quarter, with retrospective application required. The Company currently does not hold any financial or derivative instruments within the scope of this guidance that are offset in its consolidated balance sheets or are subject to an enforceable master netting arrangement. The adoption of this guidance did not have an impact on the Company’s results of operations, financial position or cash flows. | ||||||||
Recently Issued Accounting Standards | ||||||||
In July 2013, the FASB issued authoritative guidance that requires an entity to present an unrecognized tax benefit, or a portion of an unrecognized tax benefit, in the financial statements as a reduction to a deferred tax asset for a net operating loss (“NOL”) carryforward, a similar tax loss, or a tax credit carryforward. If either (i) an NOL carryforward, a similar tax loss, or tax credit carryforward is not available as of the reporting date under the governing tax law to settle taxes that would result from the disallowance of the tax position or (ii) the entity does not intend to use the deferred tax asset for this purpose (provided that the tax law permits a choice), an entity should present an unrecognized tax benefit in the financial statements as a liability and should not net the unrecognized tax benefit with a deferred tax asset. This guidance becomes effective prospectively for unrecognized tax benefits that exist as of the Company’s fiscal 2015 first quarter, with retrospective application and early adoption permitted. The Company is currently evaluating the timing of adoption and the impact of this balance sheet presentation guidance but does not expect it to have a significant impact on the Company’s consolidated financial statements. | ||||||||
In March 2013, the FASB issued authoritative guidance to resolve the diversity in practice concerning the release of the cumulative translation adjustment (“CTA”) into net income (i) when a parent sells a part or all of its investment in a foreign entity or no longer holds a controlling financial interest in a subsidiary or group of assets within a foreign entity, and (ii) in connection with a step acquisition of a foreign entity. This amended guidance requires that CTA be released in net income only if the sale or transfer results in the complete or substantially complete liquidation of the foreign entity in which the subsidiary or group of assets had resided, and that a pro rata portion of the CTA be released into net income upon a partial sale of an equity method investment in a foreign entity only. In addition, the amended guidance clarifies the definition of a sale of an investment in a foreign entity to include both, events that result in the loss of a controlling financial interest in a foreign entity and events that result in an acquirer obtaining control of an acquiree in which it held an equity interest immediately prior to the date of acquisition. The CTA should be released into net income upon the occurrence of such events. This guidance becomes effective prospectively for the Company’s fiscal 2015 first quarter with early adoption permitted. The Company will apply this new guidance when it becomes effective, and the adoption of this guidance is not expected to have a significant impact on its consolidated financial statements. | ||||||||
In February 2013, the FASB issued authoritative guidance for the recognition, measurement, and disclosure of obligations resulting from joint and several liability arrangements for which the total amount of the obligations within the scope of this guidance is fixed at the reporting date. It does not apply to certain obligations that are addressed within existing guidance in U.S. GAAP. This guidance requires an entity to measure in-scope obligations with joint and several liability (e.g., debt arrangements, other contractual obligations, settled litigations, judicial rulings) as the sum of the amount the reporting entity agreed to pay on the basis of its arrangement among its co-obligors and any additional amount it expects to pay on behalf of its co-obligors. In addition, an entity is required to disclose the nature and amount of the obligation. This guidance should be applied retrospectively to all prior periods for those obligations resulting from joint and several liability arrangements within the scope of this guidance that exist at the beginning of the Company’s fiscal 2015 first quarter, with early adoption permitted. The Company will apply this guidance when it becomes effective, and the adoption of this guidance is not expected to have a significant impact on its consolidated financial statements. | ||||||||
SUMMARY_OF_SIGNIFICANT_ACCOUNT2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) | 3 Months Ended | |||||||
Sep. 30, 2013 | ||||||||
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | ' | |||||||
Inventory and Promotional Merchandise | ' | |||||||
September 30 | June 30 | |||||||
(In millions) | 2013 | 2013 | ||||||
Raw materials | $ | 315.7 | $ | 274.2 | ||||
Work in process | 139.5 | 116.8 | ||||||
Finished goods | 568.8 | 510.9 | ||||||
Promotional merchandise | 172.3 | 212 | ||||||
$ | 1,196.30 | $ | 1,113.90 | |||||
Property, Plant and Equipment | ' | |||||||
September 30 | June 30 | |||||||
(In millions) | 2013 | 2013 | ||||||
Assets (Useful Life) | ||||||||
Land | $ | 14.9 | $ | 14.7 | ||||
Buildings and improvements (10 to 40 years) | 199.8 | 195.4 | ||||||
Machinery and equipment (3 to 10 years) | 665.4 | 647.9 | ||||||
Computer hardware and software (4 to 10 years) | 963.9 | 948.4 | ||||||
Furniture and fixtures (5 to 10 years) | 72.2 | 71.6 | ||||||
Leasehold improvements | 1,424.10 | 1,349.60 | ||||||
3,340.30 | 3,227.60 | |||||||
Less accumulated depreciation and amortization | 1,975.90 | 1,876.90 | ||||||
$ | 1,364.40 | $ | 1,350.70 | |||||
Other accrued liabilities | ' | |||||||
September 30 | June 30 | |||||||
(In millions) | 2013 | 2013 | ||||||
Advertising, merchandising and sampling | $ | 377.2 | $ | 338.4 | ||||
Employee compensation | 328.7 | 433.3 | ||||||
Payroll and other taxes | 167.4 | 135.7 | ||||||
Accrued income taxes | 177.4 | 81.3 | ||||||
Other | 459.1 | 445.9 | ||||||
$ | 1,509.80 | $ | 1,434.60 |
GOODWILL_AND_OTHER_INTANGIBLE_1
GOODWILL AND OTHER INTANGIBLE ASSETS (Tables) | 3 Months Ended | |||||||||||||||||||
Sep. 30, 2013 | ||||||||||||||||||||
GOODWILL AND OTHER INTANGIBLE ASSETS | ' | |||||||||||||||||||
Schedule of goodwill by product category and related change in the carrying amount | ' | |||||||||||||||||||
(In millions) | Skin Care | Makeup | Fragrance | Hair Care | Total | |||||||||||||||
Balance as of June 30, 2013 | ||||||||||||||||||||
Goodwill | $ | 67.7 | $ | 430.4 | $ | 54.8 | $ | 401.6 | $ | 954.5 | ||||||||||
Accumulated impairments | (32.5 | ) | — | — | (40.5 | ) | (73.0 | ) | ||||||||||||
35.2 | 430.4 | 54.8 | 361.1 | 881.5 | ||||||||||||||||
Goodwill acquired during the period | — | 3 | — | — | 3 | |||||||||||||||
Translation and other adjustments | 0.1 | 0.1 | — | 0.7 | 0.9 | |||||||||||||||
0.1 | 3.1 | — | 0.7 | 3.9 | ||||||||||||||||
Balance as of September 30, 2013 | ||||||||||||||||||||
Goodwill | 68.7 | 433.5 | 54.8 | 402.9 | 959.9 | |||||||||||||||
Accumulated impairments | (33.4 | ) | — | — | (41.1 | ) | (74.5 | ) | ||||||||||||
$ | 35.3 | $ | 433.5 | $ | 54.8 | $ | 361.8 | $ | 885.4 | |||||||||||
Other intangible assets, by type | ' | |||||||||||||||||||
September 30, 2013 | June 30, 2013 | |||||||||||||||||||
(In millions) | Gross | Accumulated | Total Net | Gross | Accumulated | Total Net | ||||||||||||||
Carrying | Amortization | Book | Carrying | Amortization | Book | |||||||||||||||
Value | Value | Value | Value | |||||||||||||||||
Amortizable intangible assets: | ||||||||||||||||||||
Customer lists and other | $ | 268.2 | $ | 207.4 | $ | 60.8 | $ | 268 | $ | 204.1 | $ | 63.9 | ||||||||
License agreements | 43 | 43 | — | 43 | 43 | — | ||||||||||||||
$ | 311.2 | $ | 250.4 | 60.8 | $ | 311 | $ | 247.1 | 63.9 | |||||||||||
Non-amortizable intangible assets: | ||||||||||||||||||||
Trademarks and other | 105.7 | 105.7 | ||||||||||||||||||
Total intangible assets | $ | 166.5 | $ | 169.6 |
RETURNS_AND_CHARGES_ASSOCIATED1
RETURNS AND CHARGES ASSOCIATED WITH RESTRUCTURING ACTIVITIES (Tables) | 3 Months Ended | ||||||||||||||||
Sep. 30, 2013 | |||||||||||||||||
RETURNS AND CHARGES ASSOCIATED WITH RESTRUCTURING ACTIVITIES | ' | ||||||||||||||||
Schedule of aggregate restructuring charges related to the Program | ' | ||||||||||||||||
(In millions) | Employee- | Asset | Contract | Other Exit | Total | ||||||||||||
Related | Write-offs | Terminations | Costs | ||||||||||||||
Costs | |||||||||||||||||
Fiscal 2009 | $ | 60.9 | $ | 4.2 | $ | 3.4 | $ | 1.8 | $ | 70.3 | |||||||
Fiscal 2010 | 29.3 | 11 | 2.3 | 6.2 | 48.8 | ||||||||||||
Fiscal 2011 | 34.6 | 2.4 | 3 | 1.1 | 41.1 | ||||||||||||
Fiscal 2012 | 37.1 | 1.7 | 12.6 | 2.2 | 53.6 | ||||||||||||
Fiscal 2013 | 7.7 | 2.1 | 1.5 | 3.3 | 14.6 | ||||||||||||
Three months ended September 30, 2013 | 0.1 | — | 1.1 | — | 1.2 | ||||||||||||
Charges recorded through September 30, 2013 | $ | 169.7 | $ | 21.4 | $ | 23.9 | $ | 14.6 | $ | 229.6 | |||||||
Schedule of accrued restructuring charges and related activity under the Program to date | ' | ||||||||||||||||
(In millions) | Employee- | Asset | Contract | Other Exit | Total | ||||||||||||
Related | Write-offs | Terminations | Costs | ||||||||||||||
Costs | |||||||||||||||||
Balance at June 30, 2013 | $ | 27.5 | $ | — | $ | 0.2 | $ | 0.7 | $ | 28.4 | |||||||
Charges | 0.1 | — | 1.1 | — | 1.2 | ||||||||||||
Cash payments | (5.7 | ) | — | (0.3 | ) | (0.3 | ) | (6.3 | ) | ||||||||
Translation adjustments | 0.1 | — | — | — | 0.1 | ||||||||||||
Balance at September 30, 2013 | $ | 22 | $ | — | $ | 1 | $ | 0.4 | $ | 23.4 |
DERIVATIVE_FINANCIAL_INSTRUMEN1
DERIVATIVE FINANCIAL INSTRUMENTS (Tables) | 3 Months Ended | |||||||||||||||||
Sep. 30, 2013 | ||||||||||||||||||
DERIVATIVE FINANCIAL INSTRUMENTS | ' | |||||||||||||||||
Schedule of fair values of the derivative financial instruments included in the consolidated balance sheets | ' | |||||||||||||||||
Asset Derivatives | Liability Derivatives | |||||||||||||||||
Balance Sheet | Fair Value (1) | Balance Sheet | Fair Value (1) | |||||||||||||||
Location | Location | |||||||||||||||||
(In millions) | September 30 | June 30 | September 30 | June 30 | ||||||||||||||
2013 | 2013 | 2013 | 2013 | |||||||||||||||
Derivatives Designated as Hedging Instruments: | ||||||||||||||||||
Foreign currency forward contracts | Prepaid expenses and other current assets | $ | 8.1 | $ | 20.8 | Other accrued liabilities | $ | 11.5 | $ | 6.4 | ||||||||
Derivatives Not Designated as Hedging Instruments: | ||||||||||||||||||
Foreign currency forward contracts | Prepaid expenses and other current assets | 4.4 | 0.9 | Other accrued liabilities | 3.2 | 2.7 | ||||||||||||
Total Derivatives | $ | 12.5 | $ | 21.7 | $ | 14.7 | $ | 9.1 | ||||||||||
(1) See Note 5 — Fair Value Measurements for further information about how the fair value of derivative assets and liabilities are determined. | ||||||||||||||||||
Schedule of gains and losses related to derivative financial instruments designated as hedging instruments | ' | |||||||||||||||||
Amount of Gain or (Loss) | Location of Gain or | Amount of Gain or (Loss) | ||||||||||||||||
Recognized in OCI on | (Loss) Reclassified | Reclassified from AOCI | ||||||||||||||||
Derivatives (Effective Portion) | from AOCI into | into Earnings | ||||||||||||||||
Earnings (Effective | (Effective Portion) (1) | |||||||||||||||||
Portion) | ||||||||||||||||||
Three Months Ended | Three Months Ended | |||||||||||||||||
September 30 | September 30 | |||||||||||||||||
(In millions) | 2013 | 2012 | 2013 | 2012 | ||||||||||||||
Derivatives in Cash Flow Hedging Relationships: | ||||||||||||||||||
Foreign currency forward contracts | $ | (13.6 | ) | $ | (13.5 | ) | Cost of sales | $ | 1.4 | $ | (0.1 | ) | ||||||
Selling, general and administrative | 2.4 | 2.5 | ||||||||||||||||
Total derivatives | $ | (13.6 | ) | $ | (13.5 | ) | $ | 3.8 | $ | 2.4 | ||||||||
(1) The amount of net loss recognized in earnings related to the amount excluded from effectiveness testing was $0.1 million for the three months ended September 30, 2013 and 2012. The net loss recognized in earnings related to the ineffective portion of the hedging relationships was $0.5 million for the three months ended September 30, 2013. There was no gain (loss) recognized in earnings related to the ineffective portion of the hedging relationships for the three months ended September 30, 2012. | ||||||||||||||||||
Schedule of gains and losses related to derivative financial instruments not designated as hedging instruments | ' | |||||||||||||||||
Location of Gain or (Loss) | Amount of Gain or (Loss) | |||||||||||||||||
Recognized in Earnings on | Recognized in Earnings on | |||||||||||||||||
Derivatives | Derivatives | |||||||||||||||||
Three Months Ended | ||||||||||||||||||
September 30 | ||||||||||||||||||
(In millions) | 2013 | 2012 | ||||||||||||||||
Derivatives Not Designated as Hedging Instruments: | ||||||||||||||||||
Foreign currency forward contracts | Selling, general and administrative | $ | 3 | $ | 2.1 | |||||||||||||
FAIR_VALUE_MEASUREMENTS_Tables
FAIR VALUE MEASUREMENTS (Tables) | 3 Months Ended | |||||||||||||
Sep. 30, 2013 | ||||||||||||||
FAIR VALUE MEASUREMENTS | ' | |||||||||||||
Financial assets and liabilities measured at fair value on a recurring basis | ' | |||||||||||||
The following table presents the Company’s hierarchy for its financial assets and liabilities measured at fair value on a recurring basis as of September 30, 2013: | ||||||||||||||
(In millions) | Level 1 | Level 2 | Level 3 | Total | ||||||||||
Assets: | ||||||||||||||
Foreign currency forward contracts | $ | — | $ | 12.5 | $ | — | $ | 12.5 | ||||||
Available-for-sale securities | 7 | — | — | 7 | ||||||||||
Total | $ | 7 | $ | 12.5 | $ | — | $ | 19.5 | ||||||
Liabilities: | ||||||||||||||
Foreign currency forward contracts | $ | — | $ | 14.7 | $ | — | $ | 14.7 | ||||||
The following table presents the Company’s hierarchy for its financial assets and liabilities measured at fair value on a recurring basis as of June 30, 2013: | ||||||||||||||
(In millions) | Level 1 | Level 2 | Level 3 | Total | ||||||||||
Assets: | ||||||||||||||
Foreign currency forward contracts | $ | — | $ | 21.7 | $ | — | $ | 21.7 | ||||||
Available-for-sale securities | 6.5 | — | — | 6.5 | ||||||||||
Total | $ | 6.5 | $ | 21.7 | $ | — | $ | 28.2 | ||||||
Liabilities: | ||||||||||||||
Foreign currency forward contracts | $ | — | $ | 9.1 | $ | — | $ | 9.1 | ||||||
Estimated fair values of financial instruments | ' | |||||||||||||
September 30 | June 30 | |||||||||||||
2013 | 2013 | |||||||||||||
(In millions) | Carrying | Fair | Carrying | Fair | ||||||||||
Amount | Value | Amount | Value | |||||||||||
Nonderivatives | ||||||||||||||
Cash and cash equivalents | $ | 1,322.20 | $ | 1,322.20 | $ | 1,495.70 | $ | 1,495.70 | ||||||
Available-for-sale securities | 7 | 7 | 6.5 | 6.5 | ||||||||||
Note receivable | 16.8 | 16.9 | 16.8 | 16.9 | ||||||||||
Current and long-term debt | 1,340.60 | 1,377.40 | 1,344.30 | 1,387.80 | ||||||||||
Derivatives | ||||||||||||||
Foreign currency forward contracts — asset (liability) | (2.2 | ) | (2.2 | ) | 12.6 | 12.6 | ||||||||
PENSION_AND_POSTRETIREMENT_BEN1
PENSION AND POST-RETIREMENT BENEFIT PLANS (Tables) | 3 Months Ended | |||||||||||||||||||
Sep. 30, 2013 | ||||||||||||||||||||
PENSION AND POST-RETIREMENT BENEFIT PLANS | ' | |||||||||||||||||||
Components of net periodic benefit cost for pension and other post-retirement benefit plans | ' | |||||||||||||||||||
Pension Plans | Other than | |||||||||||||||||||
Pension Plans | ||||||||||||||||||||
U.S. | International | Post-retirement | ||||||||||||||||||
(In millions) | 2013 | 2012 | 2013 | 2012 | 2013 | 2012 | ||||||||||||||
Service cost | $ | 7.9 | $ | 8.5 | $ | 6.1 | $ | 5.9 | $ | 0.9 | $ | 1.2 | ||||||||
Interest cost | 7.7 | 6.7 | 4.6 | 4.5 | 2 | 1.9 | ||||||||||||||
Expected return on plan assets | (11.7 | ) | (11.3 | ) | (5.0 | ) | (4.8 | ) | (0.5 | ) | (0.5 | ) | ||||||||
Amortization of: | ||||||||||||||||||||
Prior service cost | 0.2 | 0.1 | 0.7 | 0.7 | 0.2 | 0.2 | ||||||||||||||
Actuarial loss | 1.9 | 3.6 | 2.2 | 2.3 | 0.2 | 1.1 | ||||||||||||||
Settlements and curtailments | — | — | — | 0.8 | — | — | ||||||||||||||
Net periodic benefit cost | $ | 6 | $ | 7.6 | $ | 8.6 | $ | 9.4 | $ | 2.8 | $ | 3.9 | ||||||||
Schedule of amounts recognized in the consolidated balance sheets related to the entity's pension and post-retirement benefit plans | ' | |||||||||||||||||||
September 30 | June 30 | |||||||||||||||||||
(In millions) | 2013 | 2013 | ||||||||||||||||||
Other assets | $ | 145.2 | $ | 144 | ||||||||||||||||
Other accrued liabilities | (23.2 | ) | (23.1 | ) | ||||||||||||||||
Other noncurrent liabilities | (358.4 | ) | (349.2 | ) | ||||||||||||||||
Funded status | (236.4 | ) | (228.3 | ) | ||||||||||||||||
Accumulated other comprehensive loss | 315 | 315 | ||||||||||||||||||
Net amount recognized | $ | 78.6 | $ | 86.7 |
STOCKBASED_COMPENSATION_Tables
STOCK-BASED COMPENSATION (Tables) | 3 Months Ended | |||||||||||
Sep. 30, 2013 | ||||||||||||
STOCK-BASED COMPENSATION | ' | |||||||||||
Schedule of stock-based compensation expense and related income tax benefits | ' | |||||||||||
Three Months Ended | ||||||||||||
September 30 | ||||||||||||
(In millions) | 2013 | 2012 | ||||||||||
Compensation expense | $ | 56.3 | $ | 54.5 | ||||||||
Income tax benefit | 18.3 | 17.6 | ||||||||||
Summary of stock option programs and changes | ' | |||||||||||
(Shares in thousands) | Shares | Weighted- | Aggregate | Weighted- | ||||||||
Average | Intrinsic | Average | ||||||||||
Exercise | Value (1) | Contractual Life | ||||||||||
Price Per | (in millions) | Remaining in | ||||||||||
Share | Years | |||||||||||
Outstanding at June 30, 2013 | 15,071.40 | $ | 36.6 | |||||||||
Granted at fair value | 1,805.60 | 67.31 | ||||||||||
Exercised | (298.5 | ) | 27.15 | |||||||||
Expired | (4.5 | ) | 24.35 | |||||||||
Forfeited | (37.5 | ) | 50.25 | |||||||||
Outstanding at September 30, 2013 | 16,536.50 | 40.09 | $ | 492.9 | 7.1 | |||||||
Vested and expected to vest at September 30, 2013 | 16,346.00 | 39.85 | $ | 491.3 | 7 | |||||||
Exercisable at September 30, 2013 | 8,286.20 | 26.77 | $ | 357.4 | 5.7 | |||||||
(1) The intrinsic value of a stock option is the amount by which the market value of the underlying stock exceeds the exercise price of the option. | ||||||||||||
Summary of the per-share weighted-average grant date fair value of stock options granted and total intrinsic value of stock options exercised | ' | |||||||||||
Three Months Ended | ||||||||||||
September 30 | ||||||||||||
(In millions, except per share data) | 2013 | 2012 | ||||||||||
Per-share weighted-average grant date fair value of stock options granted | $ | 23.03 | $ | 20.36 | ||||||||
Intrinsic value of stock options exercised | $ | 10.8 | $ | 27.3 | ||||||||
Schedule of fair value option pricing assumptions | ' | |||||||||||
Three Months Ended | ||||||||||||
September 30 | ||||||||||||
2013 | 2012 | |||||||||||
Weighted-average expected stock-price volatility | 33% | 34% | ||||||||||
Weighted-average expected option life | 7 years | 8 years | ||||||||||
Average risk-free interest rate | 2.50% | 1.20% | ||||||||||
Average dividend yield | 1.10% | 1.00% | ||||||||||
Summary of the status of Performance Share Units, (PSUs) and activity | ' | |||||||||||
Weighted-Average | ||||||||||||
Grant Date | ||||||||||||
(Shares in thousands) | Shares | Fair Value Per | ||||||||||
Share | ||||||||||||
Nonvested at June 30, 2013 | 510.9 | $ | 53.73 | |||||||||
Granted | 284.4 | 67.31 | ||||||||||
Vested | — | — | ||||||||||
Forfeited | — | — | ||||||||||
Nonvested at September 30, 2013 | 795.3 | 58.59 | ||||||||||
Summary of the status of Restricted Stock Units (RSUs) and activity | ' | |||||||||||
Weighted-Average | ||||||||||||
Grant Date | ||||||||||||
(Shares in thousands) | Shares | Fair Value Per | ||||||||||
Share | ||||||||||||
Nonvested at June 30, 2013 | 2,222.80 | $ | 52.68 | |||||||||
Granted | 1,281.00 | 65.97 | ||||||||||
Vested | — | — | ||||||||||
Forfeited | (23.1 | ) | 55.27 | |||||||||
Nonvested at September 30, 2013 | 3,480.70 | 57.55 | ||||||||||
Summary of the status of share units and activity under the Non-Employee Director Share Incentive Plan | ' | |||||||||||
Weighted-Average | ||||||||||||
Grant Date | ||||||||||||
(Shares in thousands) | Shares | Fair Value Per | ||||||||||
Share | ||||||||||||
Outstanding at June 30, 2013 | 87.3 | $ | 33.27 | |||||||||
Granted | — | — | ||||||||||
Dividend equivalents | 0.2 | 71.11 | ||||||||||
Converted | — | — | ||||||||||
Outstanding at September 30, 2013 | 87.5 | 33.36 | ||||||||||
NET_EARNINGS_ATTRIBUTABLE_TO_T1
NET EARNINGS ATTRIBUTABLE TO THE ESTEE LAUDER COMPANIES INC. PER COMMON SHARE (Tables) | 3 Months Ended | |||||||
Sep. 30, 2013 | ||||||||
NET EARNINGS ATTRIBUTABLE TO THE ESTEE LAUDER COMPANIES INC. PER COMMON SHARE | ' | |||||||
Schedule of reconciliation between the numerators and denominators of the basic and diluted EPS computations | ' | |||||||
Three Months Ended | ||||||||
September 30 | ||||||||
(In millions, except per share data) | 2013 | 2012 | ||||||
Numerator: | ||||||||
Net earnings attributable to The Estée Lauder Companies Inc. | $ | 300.7 | $ | 299.5 | ||||
Denominator: | ||||||||
Weighted-average common shares outstanding — Basic | 387.8 | 387.8 | ||||||
Effect of dilutive stock options | 5.1 | 5.7 | ||||||
Effect of RSUs | 1.6 | 1.7 | ||||||
Effect of PSUs based on TSR | 0.1 | — | ||||||
Effect of MSU | 0.3 | 0.3 | ||||||
Weighted-average common shares outstanding — Diluted | 394.9 | 395.5 | ||||||
Net earnings attributable to The Estée Lauder Companies Inc. per common share: | ||||||||
Basic | $ | 0.78 | $ | 0.77 | ||||
Diluted | 0.76 | 0.76 |
EQUITY_Tables
EQUITY (Tables) | 3 Months Ended | |||||||||||||||||||||||||
Sep. 30, 2013 | ||||||||||||||||||||||||||
EQUITY | ' | |||||||||||||||||||||||||
Schedule of equity | ' | |||||||||||||||||||||||||
Total Stockholders’ Equity — The Estée Lauder Companies Inc. | Non- | |||||||||||||||||||||||||
(In millions) | Common | Paid-in | Retained | AOCI | Treasury | Total | controlling | Total | ||||||||||||||||||
Stock | Capital | Earnings | Stock | Interests | Equity | |||||||||||||||||||||
Balance at June 30, 2013 | $ | 5.6 | $ | 2,289.90 | $ | 5,364.10 | $ | (157.5 | ) | $ | (4,215.2 | ) | $ | 3,286.90 | $ | 15 | $ | 3,301.90 | ||||||||
Net earnings | — | — | 300.7 | — | — | 300.7 | 1.1 | 301.8 | ||||||||||||||||||
Common stock dividends - cash | — | — | (70.1 | ) | — | — | (70.1 | ) | — | (70.1 | ) | |||||||||||||||
Other comprehensive income | — | — | — | 61.2 | — | 61.2 | 0.6 | 61.8 | ||||||||||||||||||
Acquisition of treasury stock | — | — | — | — | (41.8 | ) | (41.8 | ) | — | (41.8 | ) | |||||||||||||||
Stock-based compensation | — | 76 | — | — | (17.1 | ) | 58.9 | — | 58.9 | |||||||||||||||||
Balance at September 30, 2013 | $ | 5.6 | $ | 2,365.90 | $ | 5,594.70 | $ | (96.3 | ) | $ | (4,274.1 | ) | $ | 3,595.80 | $ | 16.7 | $ | 3,612.50 | ||||||||
Summary of quarterly cash dividends declared per share on the Company's Class A and Class B Common Stock | ' | |||||||||||||||||||||||||
Date Declared | Record Date | Payable Date | Amount per Share | |||||||||||||||||||||||
August 14, 2013 | August 30, 2013 | September 16, 2013 | $ | 0.18 | ||||||||||||||||||||||
Schedule of changes in AOCI, net of tax by component | ' | |||||||||||||||||||||||||
(In millions) | Net | Net | Amounts | Translation | Total | |||||||||||||||||||||
Unrealized | Derivative | Included in | Adjustments | |||||||||||||||||||||||
Investment | Instrument | Net Periodic | ||||||||||||||||||||||||
Gain (Loss) | Gain (Loss) | Benefit Cost | ||||||||||||||||||||||||
Balance at June 30, 2013 | $ | 0.8 | $ | 18.3 | $ | (213.7 | ) | $ | 37.1 | $ | (157.5 | ) | ||||||||||||||
OCI before reclassifications | 0.2 | (8.7 | ) | (4.1 | )(1) | 72.5 | 59.9 | |||||||||||||||||||
Amounts reclassified from AOCI | — | (2.5 | ) | 3.8 | — | 1.3 | ||||||||||||||||||||
Net current-period OCI | 0.2 | (11.2 | ) | (0.3 | ) | 72.5 | 61.2 | |||||||||||||||||||
Balance at September 30, 2013 | $ | 1 | $ | 7.1 | $ | (214.0 | ) | $ | 109.6 | $ | (96.3 | ) | ||||||||||||||
(1) Includes foreign currency translation losses of $5.4 million. | ||||||||||||||||||||||||||
Schedule of effects of reclassification adjustments from AOCI into net earnings | ' | |||||||||||||||||||||||||
Amount Reclassified | ||||||||||||||||||||||||||
from AOCI | ||||||||||||||||||||||||||
(In millions) | Three Months Ended | Affected Line Item in Consolidated | ||||||||||||||||||||||||
September 30, 2013 | Statement of Earnings | |||||||||||||||||||||||||
Gain (Loss) on Cash-Flow Hedges | ||||||||||||||||||||||||||
Foreign currency forward contracts | $ | 1.4 | Cost of sales | |||||||||||||||||||||||
Foreign currency forward contracts | 2.4 | Selling, general and administrative | ||||||||||||||||||||||||
3.8 | Earnings before income taxes | |||||||||||||||||||||||||
Benefit (provision) for deferred taxes | (1.4 | ) | Provision for income taxes | |||||||||||||||||||||||
$ | 2.4 | Net earnings | ||||||||||||||||||||||||
Gain (Loss) on Fair-Value Hedges | ||||||||||||||||||||||||||
Settled interest rate-related derivatives | $ | 0.1 | Interest expense, net | |||||||||||||||||||||||
Benefit (provision) for deferred taxes | — | Provision for income taxes | ||||||||||||||||||||||||
$ | 0.1 | Net earnings | ||||||||||||||||||||||||
Amounts Included in Net Periodic Benefit Cost | ||||||||||||||||||||||||||
Amortization of prior service cost | $ | (1.1 | ) | -1 | ||||||||||||||||||||||
Amortization of actuarial loss | (4.3 | ) | -1 | |||||||||||||||||||||||
(5.4 | ) | Earnings before income taxes | ||||||||||||||||||||||||
Benefit (provision) for deferred taxes | 1.6 | Provision for income taxes | ||||||||||||||||||||||||
$ | (3.8 | ) | Net earnings | |||||||||||||||||||||||
Total reclassification adjustments, net | $ | (1.3 | ) | Net earnings | ||||||||||||||||||||||
(1) See Note 6 — Pension and Post-Retirement Benefit Plans for additional information. |
STATEMENT_OF_CASH_FLOWS_Tables
STATEMENT OF CASH FLOWS (Tables) | 3 Months Ended | |||||||
Sep. 30, 2013 | ||||||||
STATEMENT OF CASH FLOWS | ' | |||||||
Supplemental cash flow information | ' | |||||||
(In millions) | 2013 | 2012 | ||||||
Cash: | ||||||||
Cash paid during the period for interest | $ | 8.7 | $ | 27.5 | ||||
Cash paid during the period for income taxes | $ | 50.8 | $ | 67.3 | ||||
Non-cash investing and financing activities: | ||||||||
Incremental tax benefit from the exercise of stock options | $ | (0.8 | ) | $ | (1.8 | ) | ||
Capital lease obligations incurred | $ | 1.7 | $ | 0.6 |
SEGMENT_DATA_AND_RELATED_INFOR1
SEGMENT DATA AND RELATED INFORMATION (Tables) | 3 Months Ended | |||||||
Sep. 30, 2013 | ||||||||
SEGMENT DATA AND RELATED INFORMATION | ' | |||||||
Schedule of segment data and related information | ' | |||||||
Three Months Ended | ||||||||
September 30 | ||||||||
(In millions) | 2013 | 2012 | ||||||
PRODUCT CATEGORY DATA | ||||||||
Net Sales: | ||||||||
Skin Care | $ | 1,171.00 | $ | 1,113.50 | ||||
Makeup | 1,001.00 | 960.4 | ||||||
Fragrance | 367.4 | 347.6 | ||||||
Hair Care | 124.8 | 113.9 | ||||||
Other | 10.8 | 14.1 | ||||||
Net Sales | $ | 2,675.00 | $ | 2,549.50 | ||||
Operating Income (Loss) before total charges associated with restructuring activities: | ||||||||
Skin Care | $ | 241.6 | $ | 259 | ||||
Makeup | 166.3 | 161.3 | ||||||
Fragrance | 36.9 | 53.4 | ||||||
Hair Care | 8.4 | 10.7 | ||||||
Other | (2.5 | ) | (2.0 | ) | ||||
450.7 | 482.4 | |||||||
Reconciliation: | ||||||||
Total charges associated with restructuring activities | (1.2 | ) | (0.4 | ) | ||||
Interest expense, net | (13.5 | ) | (15.8 | ) | ||||
Interest expense on debt extinguishment | — | (19.1 | ) | |||||
Other income | — | 1.8 | ||||||
Earnings before income taxes | $ | 436 | $ | 448.9 | ||||
GEOGRAPHIC DATA | ||||||||
Net Sales: | ||||||||
The Americas | $ | 1,202.40 | $ | 1,182.10 | ||||
Europe, the Middle East & Africa | 891.2 | 824.9 | ||||||
Asia/Pacific | 581.4 | 542.5 | ||||||
Net Sales | $ | 2,675.00 | $ | 2,549.50 | ||||
Operating Income (Loss): | ||||||||
The Americas | $ | 156 | $ | 172.3 | ||||
Europe, the Middle East & Africa | 180.8 | 196.9 | ||||||
Asia/Pacific | 113.9 | 113.2 | ||||||
450.7 | 482.4 | |||||||
Total charges associated with restructuring activities | (1.2 | ) | (0.4 | ) | ||||
Operating Income | $ | 449.5 | $ | 482 |
SUMMARY_OF_SIGNIFICANT_ACCOUNT3
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) (USD $) | 3 Months Ended | 3 Months Ended | 12 Months Ended | ||||
In Millions, unless otherwise specified | Sep. 30, 2013 | Sep. 30, 2012 | Jun. 30, 2013 | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Jun. 30, 2013 |
Net Sales | Net Sales | Accounts Receivable | Accounts Receivable | ||||
Largest Customer | Largest Customer | Largest Customer | Largest Customer | ||||
Currency Translation and Transactions | ' | ' | ' | ' | ' | ' | ' |
Unrealized translation gains, net of tax | $72.50 | $76.50 | ' | ' | ' | ' | ' |
Net exchange gains on foreign currency transactions | 0.1 | 0.9 | ' | ' | ' | ' | ' |
Accounts Receivable | ' | ' | ' | ' | ' | ' | ' |
Allowance for doubtful accounts and customer deductions | 23.5 | ' | 22.7 | ' | ' | ' | ' |
Concentration of Credit Risk | ' | ' | ' | ' | ' | ' | ' |
Net Sales | 2,675 | 2,549.50 | ' | 341.6 | 336.2 | ' | ' |
Accounts receivable, net | 1,566.70 | ' | 1,171.70 | ' | ' | 251.6 | 113.7 |
Concentration of credit risk (as a percent) | ' | ' | ' | 13.00% | 13.00% | 16.00% | 10.00% |
Inventory and Promotional Merchandise | ' | ' | ' | ' | ' | ' | ' |
Raw materials | 315.7 | ' | 274.2 | ' | ' | ' | ' |
Work in process | 139.5 | ' | 116.8 | ' | ' | ' | ' |
Finished goods | 568.8 | ' | 510.9 | ' | ' | ' | ' |
Promotional merchandise | 172.3 | ' | 212 | ' | ' | ' | ' |
Inventory and promotional merchandise, net | $1,196.30 | ' | $1,113.90 | ' | ' | ' | ' |
SUMMARY_OF_SIGNIFICANT_ACCOUNT4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 2) (USD $) | 3 Months Ended | 3 Months Ended | 12 Months Ended | 3 Months Ended | 12 Months Ended | 3 Months Ended | 12 Months Ended | 3 Months Ended | 12 Months Ended | 3 Months Ended | 12 Months Ended | 3 Months Ended | 12 Months Ended | 3 Months Ended | 12 Months Ended | 3 Months Ended | 12 Months Ended | ||||||||||||||
In Millions, unless otherwise specified | Sep. 30, 2013 | Sep. 30, 2012 | Jun. 30, 2013 | Sep. 30, 2013 | Jun. 30, 2013 | Sep. 30, 2013 | Jun. 30, 2013 | Sep. 30, 2013 | Jun. 30, 2013 | Sep. 30, 2013 | Jun. 30, 2013 | Sep. 30, 2013 | Jun. 30, 2013 | Sep. 30, 2013 | Jun. 30, 2013 | Sep. 30, 2013 | Jun. 30, 2013 | Sep. 30, 2013 | Jun. 30, 2013 | Sep. 30, 2013 | Jun. 30, 2013 | Sep. 30, 2013 | Jun. 30, 2013 | Sep. 30, 2013 | Jun. 30, 2013 | Sep. 30, 2013 | Jun. 30, 2013 | Sep. 30, 2013 | Jun. 30, 2013 | Sep. 30, 2013 | Jun. 30, 2013 |
Land | Land | Buildings and improvements | Buildings and improvements | Buildings and improvements | Buildings and improvements | Buildings and improvements | Buildings and improvements | Machinery and equipment | Machinery and equipment | Machinery and equipment | Machinery and equipment | Machinery and equipment | Machinery and equipment | Computer hardware and software | Computer hardware and software | Computer hardware and software | Computer hardware and software | Computer hardware and software | Computer hardware and software | Furniture and fixtures | Furniture and fixtures | Furniture and fixtures | Furniture and fixtures | Furniture and fixtures | Furniture and fixtures | Leasehold improvements | Leasehold improvements | ||||
Minimum | Minimum | Maximum | Maximum | Minimum | Minimum | Maximum | Maximum | Minimum | Minimum | Maximum | Maximum | Minimum | Minimum | Maximum | Maximum | ||||||||||||||||
Property, Plant and Equipment | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Property, Plant and Equipment | $3,340.30 | ' | $3,227.60 | $14.90 | $14.70 | $199.80 | $195.40 | ' | ' | ' | ' | $665.40 | $647.90 | ' | ' | ' | ' | $963.90 | $948.40 | ' | ' | ' | ' | $72.20 | $71.60 | ' | ' | ' | ' | $1,424.10 | $1,349.60 |
Property, Plant and Equipment, Useful Life | ' | ' | ' | ' | ' | ' | ' | '10 years | '10 years | '40 years | '40 years | ' | ' | '3 years | '3 years | '10 years | '10 years | ' | ' | '4 years | '4 years | '10 years | '10 years | ' | ' | '5 years | '5 years | '10 years | '10 years | ' | ' |
Less accumulated depreciation and amortization | 1,975.90 | ' | 1,876.90 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Property, Plant and Equipment, net | 1,364.40 | ' | 1,350.70 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Cost of assets related to projects in progress | 163.8 | ' | 178.7 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Depreciation and amortization of property, plant and equipment | $87.10 | $75.30 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
SUMMARY_OF_SIGNIFICANT_ACCOUNT5
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 3) (USD $) | 3 Months Ended | ||
In Millions, unless otherwise specified | Sep. 30, 2013 | Sep. 30, 2012 | Jun. 30, 2013 |
Other Accrued Liabilities | ' | ' | ' |
Advertising, merchandising and sampling | $377.20 | ' | $338.40 |
Employee compensation | 328.7 | ' | 433.3 |
Payroll and other taxes | 167.4 | ' | 135.7 |
Accrued income taxes | 177.4 | ' | 81.3 |
Other | 459.1 | ' | 445.9 |
Total | 1,509.80 | ' | 1,434.60 |
Income Taxes | ' | ' | ' |
Effective tax rate (as a percent) | 30.80% | 33.30% | ' |
Gross unrecognized tax benefits | 63.5 | ' | 64 |
Total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate | 46.3 | ' | ' |
Total gross interest and penalty benefit | 0.3 | ' | ' |
Gross accrued interest and penalties related to unrecognized tax benefits | 17.7 | ' | 17.4 |
Decrease in unrecognized tax benefits, low end of range | 10 | ' | ' |
Decrease in unrecognized tax benefits, high end of range | 15 | ' | ' |
Current net deferred tax assets | 306.3 | ' | 296 |
Noncurrent net deferred tax assets | $62.70 | ' | $50.30 |
GOODWILL_AND_OTHER_INTANGIBLE_2
GOODWILL AND OTHER INTANGIBLE ASSETS (Details) (USD $) | 3 Months Ended | |
In Millions, unless otherwise specified | Sep. 30, 2013 | Jun. 30, 2013 |
Goodwill by reporting unit | ' | ' |
Goodwill, gross | $959.90 | $954.50 |
Accumulated impairments | -74.5 | -73 |
Changes in goodwill | ' | ' |
Goodwill at the beginning of the period | 881.5 | ' |
Goodwill acquired during the period | 3 | ' |
Translation and other adjustments | 0.9 | ' |
Goodwill, Period Increase (Decrease) | 3.9 | ' |
Goodwill at the end of the period | 885.4 | ' |
Skin Care | ' | ' |
Goodwill by reporting unit | ' | ' |
Goodwill, gross | 68.7 | 67.7 |
Accumulated impairments | -33.4 | -32.5 |
Changes in goodwill | ' | ' |
Goodwill at the beginning of the period | 35.2 | ' |
Translation and other adjustments | 0.1 | ' |
Goodwill, Period Increase (Decrease) | 0.1 | ' |
Goodwill at the end of the period | 35.3 | ' |
Makeup | ' | ' |
Goodwill by reporting unit | ' | ' |
Goodwill, gross | 433.5 | 430.4 |
Changes in goodwill | ' | ' |
Goodwill at the beginning of the period | 430.4 | ' |
Goodwill acquired during the period | 3 | ' |
Translation and other adjustments | 0.1 | ' |
Goodwill, Period Increase (Decrease) | 3.1 | ' |
Goodwill at the end of the period | 433.5 | ' |
Fragrance | ' | ' |
Goodwill by reporting unit | ' | ' |
Goodwill, gross | 54.8 | 54.8 |
Changes in goodwill | ' | ' |
Goodwill at the beginning of the period | ' | 54.8 |
Goodwill at the end of the period | 54.8 | 54.8 |
Hair Care | ' | ' |
Goodwill by reporting unit | ' | ' |
Goodwill, gross | 402.9 | 401.6 |
Accumulated impairments | -41.1 | -40.5 |
Changes in goodwill | ' | ' |
Goodwill at the beginning of the period | 361.1 | ' |
Translation and other adjustments | 0.7 | ' |
Goodwill, Period Increase (Decrease) | 0.7 | ' |
Goodwill at the end of the period | $361.80 | ' |
GOODWILL_AND_OTHER_INTANGIBLE_3
GOODWILL AND OTHER INTANGIBLE ASSETS (Details 2) (USD $) | 3 Months Ended | ||
In Millions, unless otherwise specified | Sep. 30, 2013 | Sep. 30, 2012 | Jun. 30, 2013 |
Amortizable intangible assets: | ' | ' | ' |
Gross Carrying Value | $311.20 | ' | $311 |
Accumulated Amortization | 250.4 | ' | 247.1 |
Total Net Book Value | 60.8 | ' | 63.9 |
Aggregate amortization expense for amortizable intangible assets | 3.2 | 3.1 | ' |
Non-amortizable intangible assets: | ' | ' | ' |
Trademarks and other | 105.7 | ' | 105.7 |
Total intangible assets | 166.5 | ' | 169.6 |
Estimated aggregate amortization expense | ' | ' | ' |
Estimated aggregate amortization expense for remainder of fiscal year 2014 | 9.3 | ' | ' |
Estimated aggregate amortization expense for fiscal year 2015 | 12.1 | ' | ' |
Estimated aggregate amortization expense for fiscal year 2016 | 12 | ' | ' |
Estimated aggregate amortization expense for fiscal year 2017 | 9.9 | ' | ' |
Estimated aggregate amortization expense for fiscal year 2018 | 8.4 | ' | ' |
Customer lists and other | ' | ' | ' |
Amortizable intangible assets: | ' | ' | ' |
Gross Carrying Value | 268.2 | ' | 268 |
Accumulated Amortization | 207.4 | ' | 204.1 |
Total Net Book Value | 60.8 | ' | 63.9 |
License agreements | ' | ' | ' |
Amortizable intangible assets: | ' | ' | ' |
Gross Carrying Value | 43 | ' | 43 |
Accumulated Amortization | $43 | ' | $43 |
RETURNS_AND_CHARGES_ASSOCIATED2
RETURNS AND CHARGES ASSOCIATED WITH RESTRUCTURING ACTIVITIES (Details) (USD $) | 3 Months Ended | 12 Months Ended | 56 Months Ended | ||||
In Millions, unless otherwise specified | Sep. 30, 2013 | Jun. 30, 2013 | Jun. 30, 2012 | Jun. 30, 2011 | Jun. 30, 2010 | Jun. 30, 2009 | Sep. 30, 2013 |
Total Restructuring Charges and Other Costs to Implement | ' | ' | ' | ' | ' | ' | ' |
Cumulative restructuring charges and other costs incurred through September 30, 2013 | ' | ' | ' | ' | ' | ' | $321.60 |
Restructuring and related activities | ' | ' | ' | ' | ' | ' | ' |
Beginning balance | 28.4 | ' | ' | ' | ' | ' | ' |
Charges | 1.2 | 14.6 | 53.6 | 41.1 | 48.8 | 70.3 | ' |
Cash payments | -6.3 | ' | ' | ' | ' | ' | ' |
Translation adjustments | 0.1 | ' | ' | ' | ' | ' | ' |
Ending balance | 23.4 | 28.4 | ' | ' | ' | ' | 23.4 |
Expected cash expenditures for restructuring charges, remainder of fiscal 2014 | 17 | ' | ' | ' | ' | ' | ' |
Expected cash expenditures for restructuring charges, fiscal 2015 | 6 | ' | ' | ' | ' | ' | ' |
Restructuring charges | ' | ' | ' | ' | ' | ' | ' |
Total Restructuring Charges and Other Costs to Implement | ' | ' | ' | ' | ' | ' | ' |
Cumulative restructuring charges and other costs incurred through September 30, 2013 | ' | ' | ' | ' | ' | ' | 229.6 |
Employee-Related Costs | ' | ' | ' | ' | ' | ' | ' |
Restructuring and related activities | ' | ' | ' | ' | ' | ' | ' |
Beginning balance | 27.5 | ' | ' | ' | ' | ' | ' |
Charges | 0.1 | 7.7 | 37.1 | 34.6 | 29.3 | 60.9 | ' |
Cash payments | -5.7 | ' | ' | ' | ' | ' | ' |
Translation adjustments | 0.1 | ' | ' | ' | ' | ' | ' |
Ending balance | 22 | 27.5 | ' | ' | ' | ' | 22 |
Employee-Related Costs | Restructuring charges | ' | ' | ' | ' | ' | ' | ' |
Total Restructuring Charges and Other Costs to Implement | ' | ' | ' | ' | ' | ' | ' |
Cumulative restructuring charges and other costs incurred through September 30, 2013 | ' | ' | ' | ' | ' | ' | 169.7 |
Asset Write-offs | ' | ' | ' | ' | ' | ' | ' |
Restructuring and related activities | ' | ' | ' | ' | ' | ' | ' |
Charges | ' | 2.1 | 1.7 | 2.4 | 11 | 4.2 | ' |
Asset Write-offs | Restructuring charges | ' | ' | ' | ' | ' | ' | ' |
Total Restructuring Charges and Other Costs to Implement | ' | ' | ' | ' | ' | ' | ' |
Cumulative restructuring charges and other costs incurred through September 30, 2013 | ' | ' | ' | ' | ' | ' | 21.4 |
Contract Terminations | ' | ' | ' | ' | ' | ' | ' |
Restructuring and related activities | ' | ' | ' | ' | ' | ' | ' |
Beginning balance | 0.2 | ' | ' | ' | ' | ' | ' |
Charges | 1.1 | 1.5 | 12.6 | 3 | 2.3 | 3.4 | ' |
Cash payments | -0.3 | ' | ' | ' | ' | ' | ' |
Ending balance | 1 | 0.2 | ' | ' | ' | ' | 1 |
Contract Terminations | Restructuring charges | ' | ' | ' | ' | ' | ' | ' |
Total Restructuring Charges and Other Costs to Implement | ' | ' | ' | ' | ' | ' | ' |
Cumulative restructuring charges and other costs incurred through September 30, 2013 | ' | ' | ' | ' | ' | ' | 23.9 |
Other Exit Costs | ' | ' | ' | ' | ' | ' | ' |
Restructuring and related activities | ' | ' | ' | ' | ' | ' | ' |
Beginning balance | 0.7 | ' | ' | ' | ' | ' | ' |
Charges | ' | 3.3 | 2.2 | 1.1 | 6.2 | 1.8 | ' |
Cash payments | -0.3 | ' | ' | ' | ' | ' | ' |
Ending balance | 0.4 | 0.7 | ' | ' | ' | ' | 0.4 |
Other Exit Costs | Restructuring charges | ' | ' | ' | ' | ' | ' | ' |
Total Restructuring Charges and Other Costs to Implement | ' | ' | ' | ' | ' | ' | ' |
Cumulative restructuring charges and other costs incurred through September 30, 2013 | ' | ' | ' | ' | ' | ' | $14.60 |
DERIVATIVE_FINANCIAL_INSTRUMEN2
DERIVATIVE FINANCIAL INSTRUMENTS (Details) (USD $) | Sep. 30, 2013 | Jun. 30, 2013 |
In Millions, unless otherwise specified | ||
Derivatives, Fair Value | ' | ' |
Total Derivative asset, fair value | $12.50 | $21.70 |
Total Derivative liability, fair value | 14.7 | 9.1 |
Derivatives designated as hedging instruments | Foreign currency forward contracts | Prepaid expenses and other current assets | ' | ' |
Derivatives, Fair Value | ' | ' |
Derivative asset, fair value | 8.1 | 20.8 |
Derivatives designated as hedging instruments | Foreign currency forward contracts | Other accrued liabilities | ' | ' |
Derivatives, Fair Value | ' | ' |
Derivative liability, fair value | 11.5 | 6.4 |
Derivatives not designated as hedging instruments | Foreign currency forward contracts | Prepaid expenses and other current assets | ' | ' |
Derivatives, Fair Value | ' | ' |
Derivative asset, fair value | 4.4 | 0.9 |
Derivatives not designated as hedging instruments | Foreign currency forward contracts | Other accrued liabilities | ' | ' |
Derivatives, Fair Value | ' | ' |
Derivative liability, fair value | $3.20 | $2.70 |
DERIVATIVE_FINANCIAL_INSTRUMEN3
DERIVATIVE FINANCIAL INSTRUMENTS (Details 2) (USD $) | 3 Months Ended | |
In Millions, unless otherwise specified | Sep. 30, 2013 | Sep. 30, 2012 |
Foreign currency forward contracts | Selling, general and administrative | Derivatives not designated as hedging instruments | ' | ' |
Gain (loss) on derivative financial instruments | ' | ' |
Amount of Gain or (Loss) Recognized in Earnings on Derivatives | $3 | $2.10 |
Derivatives in cash flow hedging relationships | ' | ' |
Gain (loss) on derivative financial instruments | ' | ' |
Amount of Gain or (Loss) Recognized in OCI on Derivatives (Effective Portion) | -13.6 | -13.5 |
Amount of Gain or (Loss) Reclassified from AOCI into Earnings (Effective Portion) | 3.8 | 2.4 |
Net loss recognized in earnings related to the amount excluded from effectiveness testing | 0.1 | 0.1 |
Net gain (loss) recognized in earnings related to the ineffective portion of the hedging relationships | -0.5 | 0 |
Derivatives in cash flow hedging relationships | Foreign currency forward contracts | ' | ' |
Gain (loss) on derivative financial instruments | ' | ' |
Amount of Gain or (Loss) Recognized in OCI on Derivatives (Effective Portion) | -13.6 | -13.5 |
Derivatives in cash flow hedging relationships | Foreign currency forward contracts | Cost of sales | ' | ' |
Gain (loss) on derivative financial instruments | ' | ' |
Amount of Gain or (Loss) Reclassified from AOCI into Earnings (Effective Portion) | 1.4 | -0.1 |
Derivatives in cash flow hedging relationships | Foreign currency forward contracts | Selling, general and administrative | ' | ' |
Gain (loss) on derivative financial instruments | ' | ' |
Amount of Gain or (Loss) Reclassified from AOCI into Earnings (Effective Portion) | $2.40 | $2.50 |
DERIVATIVE_FINANCIAL_INSTRUMEN4
DERIVATIVE FINANCIAL INSTRUMENTS (Details 3) (USD $) | Sep. 30, 2013 | Jun. 30, 2013 |
In Millions, unless otherwise specified | ||
Credit Risk | ' | ' |
Minimum number of nationally recognized rating agencies | 2 | ' |
Credit-risk-related contingent features | ' | ' |
Derivative contracts, net liability position, number of counterparties | 2 | ' |
Credit-risk-related derivative contracts in net liability position, fair value | $0.80 | ' |
Derivative | ' | ' |
Credit Risk | ' | ' |
Maximum exposure to credit risk in the event of nonperformance by counterparties, gross fair value of contracts in asset positions | 12.5 | ' |
Foreign currency forward contracts | ' | ' |
Foreign Currency Cash-Flow Hedges | ' | ' |
Estimated net gain | 0.8 | ' |
Foreign currency forward contracts | Accumulated other comprehensive income (loss) from foreign currency cash-flow hedges | ' | ' |
Foreign Currency Cash-Flow Hedges | ' | ' |
Accumulated gain (loss) on foreign currency cash-flow hedges in AOCI, before tax | -0.5 | 16.9 |
Foreign currency forward contracts | Derivatives in cash flow hedging relationships | ' | ' |
Foreign Currency Cash-Flow Hedges | ' | ' |
Notional amount of foreign currency forward contracts | 1,763.60 | ' |
British pound | Foreign currency forward contracts | Derivatives in cash flow hedging relationships | ' | ' |
Foreign Currency Cash-Flow Hedges | ' | ' |
Notional amount of foreign currency forward contracts | 420.8 | ' |
Euro | Foreign currency forward contracts | Derivatives in cash flow hedging relationships | ' | ' |
Foreign Currency Cash-Flow Hedges | ' | ' |
Notional amount of foreign currency forward contracts | 360.6 | ' |
Canadian dollar | Foreign currency forward contracts | Derivatives in cash flow hedging relationships | ' | ' |
Foreign Currency Cash-Flow Hedges | ' | ' |
Notional amount of foreign currency forward contracts | 229.4 | ' |
Australian dollar | Foreign currency forward contracts | Derivatives in cash flow hedging relationships | ' | ' |
Foreign Currency Cash-Flow Hedges | ' | ' |
Notional amount of foreign currency forward contracts | 94.2 | ' |
Swiss franc | Foreign currency forward contracts | Derivatives in cash flow hedging relationships | ' | ' |
Foreign Currency Cash-Flow Hedges | ' | ' |
Notional amount of foreign currency forward contracts | 91.3 | ' |
Hong Kong dollar | Foreign currency forward contracts | Derivatives in cash flow hedging relationships | ' | ' |
Foreign Currency Cash-Flow Hedges | ' | ' |
Notional amount of foreign currency forward contracts | 90.5 | ' |
Japanese yen | Foreign currency forward contracts | Derivatives in cash flow hedging relationships | ' | ' |
Foreign Currency Cash-Flow Hedges | ' | ' |
Notional amount of foreign currency forward contracts | $88.40 | ' |
FAIR_VALUE_MEASUREMENTS_Detail
FAIR VALUE MEASUREMENTS (Details) (USD $) | Sep. 30, 2013 | Jun. 30, 2013 |
In Millions, unless otherwise specified | ||
Assets measured at fair value | ' | ' |
Foreign currency forward contracts | $12.50 | $21.70 |
Liabilities: | ' | ' |
Foreign currency forward contracts | 14.7 | 9.1 |
Recurring basis | Level 1 | ' | ' |
Assets measured at fair value | ' | ' |
Available-for-sale securities | 7 | 6.5 |
Assets measured at fair value | 7 | 6.5 |
Recurring basis | Level 2 | ' | ' |
Assets measured at fair value | ' | ' |
Foreign currency forward contracts | 12.5 | 21.7 |
Assets measured at fair value | 12.5 | 21.7 |
Liabilities: | ' | ' |
Foreign currency forward contracts | 14.7 | 9.1 |
Recurring basis | Fair Value | ' | ' |
Assets measured at fair value | ' | ' |
Foreign currency forward contracts | 12.5 | 21.7 |
Available-for-sale securities | 7 | 6.5 |
Assets measured at fair value | 19.5 | 28.2 |
Liabilities: | ' | ' |
Foreign currency forward contracts | $14.70 | $9.10 |
FAIR_VALUE_MEASUREMENTS_Detail1
FAIR VALUE MEASUREMENTS (Details 2) (USD $) | 3 Months Ended | ||||||
In Millions, unless otherwise specified | Sep. 30, 2013 | Sep. 30, 2013 | Sep. 30, 2013 | Sep. 30, 2013 | Jun. 30, 2013 | Sep. 30, 2013 | Jun. 30, 2013 |
LIBOR | Swap yield curve | Carrying Value | Carrying Value | Fair Value | Fair Value | ||
Foreign currency forward contracts | Foreign currency forward contracts | ||||||
Estimated fair values of financial instruments | ' | ' | ' | ' | ' | ' | ' |
Implied market rate applied to fair value of the receivable related to sale of assets (as a percent) | 6.60% | ' | ' | ' | ' | ' | ' |
Basis points of increase or decrease in the risk premium that would not result in a significant change to the fair value of the receivable (as a percent) | 1.00% | ' | ' | ' | ' | ' | ' |
Nonderivatives | ' | ' | ' | ' | ' | ' | ' |
Cash and cash equivalents | ' | ' | ' | $1,322.20 | $1,495.70 | $1,322.20 | $1,495.70 |
Available-for-sale securities | ' | ' | ' | 7 | 6.5 | 7 | 6.5 |
Note receivable | ' | ' | ' | 16.8 | 16.8 | 16.9 | 16.9 |
Current and long-term debt | ' | ' | ' | 1,340.60 | 1,344.30 | 1,377.40 | 1,387.80 |
Derivatives | ' | ' | ' | ' | ' | ' | ' |
Foreign currency forward contracts - asset (liability) | ' | ' | ' | ($2.20) | $12.60 | ($2.20) | $12.60 |
Contract maturities, maximum | ' | '12 months | ' | ' | ' | ' | ' |
Contract maturities greater than | ' | ' | '12 months | ' | ' | ' | ' |
PENSION_AND_POSTRETIREMENT_BEN2
PENSION AND POST-RETIREMENT BENEFIT PLANS (Details) (USD $) | Sep. 30, 2013 | Jun. 30, 2013 | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 |
In Millions, unless otherwise specified | Pension Plans U.S. | Pension Plans U.S. | Pension Plans International | Pension Plans International | Post-retirement benefit other than pension plans | Post-retirement benefit other than pension plans | ||
Components of net periodic benefit cost: | ' | ' | ' | ' | ' | ' | ' | ' |
Service cost | ' | ' | $7.90 | $8.50 | $6.10 | $5.90 | $0.90 | $1.20 |
Interest cost | ' | ' | 7.7 | 6.7 | 4.6 | 4.5 | 2 | 1.9 |
Expected return on assets | ' | ' | -11.7 | -11.3 | -5 | -4.8 | -0.5 | -0.5 |
Amortization of: | ' | ' | ' | ' | ' | ' | ' | ' |
Prior service cost | ' | ' | 0.2 | 0.1 | 0.7 | 0.7 | 0.2 | 0.2 |
Actuarial loss | ' | ' | 1.9 | 3.6 | 2.2 | 2.3 | 0.2 | 1.1 |
Settlements and curtailments | ' | ' | ' | ' | ' | 0.8 | ' | ' |
Net periodic benefit cost | ' | ' | 6 | 7.6 | 8.6 | 9.4 | 2.8 | 3.9 |
Employer contributions | ' | ' | ' | ' | 4 | ' | ' | ' |
Amounts recognized in the consolidated balance sheets related to the entity's pension and post-retirement benefit plans consist of | ' | ' | ' | ' | ' | ' | ' | ' |
Other assets | 145.2 | 144 | ' | ' | ' | ' | ' | ' |
Other accrued liabilities | -23.2 | -23.1 | ' | ' | ' | ' | ' | ' |
Other noncurrent liabilities | -358.4 | -349.2 | ' | ' | ' | ' | ' | ' |
Funded status | -236.4 | -228.3 | ' | ' | ' | ' | ' | ' |
Accumulated other comprehensive loss | 315 | 315 | ' | ' | ' | ' | ' | ' |
Net amount recognized | $78.60 | $86.70 | ' | ' | ' | ' | ' | ' |
CONTINGENCIES_Details
CONTINGENCIES (Details) (Darphin brand litigation) | 0 Months Ended | 1 Months Ended | 3 Months Ended | |
In Millions, unless otherwise specified | Dec. 23, 2011 | Jan. 31, 2012 | Sep. 30, 2013 | Jun. 30, 2007 |
EUR (€) | EUR (€) | USD ($) | EUR (€) | |
Subsidiary | ||||
Legal Proceedings | ' | ' | ' | ' |
Number of subsidiaries included in litigation | ' | ' | 1 | ' |
Claim amount of litigation initiated | ' | ' | $81.20 | € 60 |
Amount of award | 22.9 | ' | 31 | ' |
Payment of award to former owner | ' | € 25.30 | $34.20 | ' |
STOCKBASED_COMPENSATION_Detail
STOCK-BASED COMPENSATION (Details) (USD $) | 3 Months Ended | |
In Millions, except Share data, unless otherwise specified | Sep. 30, 2013 | Sep. 30, 2012 |
Share-based Compensation Arrangement by Share-based Payment Award | ' | ' |
Compensation expense | $56.30 | $54.50 |
Income tax benefit | 18.3 | 17.6 |
Total unrecognized compensation cost related to unvested stock-based awards | 188.2 | ' |
Weighted-average period over which compensation cost related to unvested stock-based awards is expected to be recognized | '2 years | ' |
Common Class A | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award | ' | ' |
Number of Class A Common Stock shares reserved and available to be granted pursuant to equity compensation plans | 14,859,200 | ' |
Stock options | ' | ' |
Shares | ' | ' |
Outstanding at the beginning of the year (in shares) | 15,071,400 | ' |
Granted at fair value (in shares) | 1,805,600 | ' |
Exercised (in shares) | -298,500 | ' |
Expired (in shares) | -4,500 | ' |
Forfeited (in shares) | -37,500 | ' |
Outstanding at the end of the period (in shares) | 16,536,500 | ' |
Vested and expected to vest (in shares) | 16,346,000 | ' |
Exercisable (in shares) | 8,286,200 | ' |
Weighted-Average Exercise Price Per Share | ' | ' |
Outstanding at the beginning of the year (in dollars per share) | $36.60 | ' |
Granted at fair value (in dollars per share) | $67.31 | ' |
Exercised (in dollars per share) | $27.15 | ' |
Expired (in dollars per share) | $24.35 | ' |
Forfeited (in dollars per share) | $50.25 | ' |
Outstanding at the end of the period (in dollars per share) | $40.09 | ' |
Vested and expected to vest Weighted-Average Exercise Price (in dollars per share) | $39.85 | ' |
Exercisable Weighted-Average Exercise Price (in dollars per share) | $26.77 | ' |
Additional General Disclosures | ' | ' |
Outstanding Aggregate Intrinsic Value (in dollars) | 492.9 | ' |
Weighted-Average Contractual Life Remaining | '7 years 1 month 6 days | ' |
Vested and expected to vest Aggregate Intrinsic Value (in dollars) | 491.3 | ' |
Vested and expected to vest Exercisable Weighted-Average Contractual Life Remaining | '7 years | ' |
Exercisable Aggregate Intrinsic Value (in dollars) | 357.4 | ' |
Exercisable Weighted-Average Contractual Life Remaining | '5 years 8 months 12 days | ' |
Per-share weighted-average grant date fair value of stock options granted (in dollars per share) | $23.03 | $20.36 |
Intrinsic value of stock options exercised (in dollars) | $10.80 | $27.30 |
Fair Value Of Option Grants, Assumptions and Methodology | ' | ' |
Method used for estimating fair value of option grant | 'Black-Scholes | ' |
Weighted-average expected stock-price volatility (as a percent) | 33.00% | 34.00% |
Weighted-average expected option life | '7 years | '8 years |
Average risk-free interest rate (as a percent) | 2.50% | 1.20% |
Average dividend yield (as a percent) | 1.10% | 1.00% |
STOCKBASED_COMPENSATION_Detail1
STOCK-BASED COMPENSATION (Details 2) (USD $) | 3 Months Ended | 12 Months Ended | 1 Months Ended | 3 Months Ended | 12 Months Ended | 3 Months Ended | ||||||||||||
In Millions, except Share data, unless otherwise specified | Sep. 30, 2013 | Jun. 30, 2013 | Sep. 30, 2013 | Sep. 30, 2013 | Sep. 30, 2013 | Sep. 30, 2013 | Sep. 30, 2013 | Sep. 30, 2013 | Sep. 30, 2013 | Sep. 30, 2013 | Sep. 30, 2013 | Sep. 30, 2013 | Jun. 30, 2013 | Sep. 30, 2013 | Sep. 30, 2013 | Sep. 30, 2013 | Sep. 30, 2013 | Sep. 30, 2012 |
Performance Share Units | Performance Share Units | Performance Share Units | Restricted Stock Units | Restricted Stock Units | Restricted Stock Units | Restricted Stock Units | Restricted Stock Units | Performance share units based on total stockholder return | Performance share units based on total stockholder return | Performance share units based on total stockholder return | Performance share units based on total stockholder return | Performance share units based on total stockholder return | Performance share units based on total stockholder return | Market Share Unit | Share Units | Cash Units | Cash Units | |
Common Class A | RSU grants scheduled to vest in fiscal 2015 | RSU grants scheduled to vest in fiscal 2016 | RSU grants scheduled to vest in fiscal 2017 | RSU grants scheduled to vest in fiscal 2018 | Performance share units based on total stockholders return vesting (contractual term 33 months) | Performance share units based on total stockholders return vesting (contractual term 45 months) | Performance share units based on total stockholders return vesting (contractual term 57 months) | Common Class A | Common Class A | |||||||||
Executive | Maximum | |||||||||||||||||
Executive | ||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Class A Common Stock issued for Performance Share Units (in shares) | ' | ' | 548,800 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Target payout for performance share units in Class A Common Stock (in shares) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 162,760 | 260,416 | ' | ' | ' | ' |
Other Equity Compensation Plans | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Nonvested at the beginning of the period (in shares) | 510,900 | ' | ' | 2,222,800 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Granted (in shares) | 284,400 | ' | ' | 1,281,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Vested (in shares) | ' | 365,900 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Forfeited (in shares) | ' | ' | ' | -23,100 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Nonvested at the end of the period (in shares) | 795,300 | 510,900 | ' | 3,480,700 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
RSU grants scheduled to vest (in shares) | ' | ' | ' | ' | 469,300 | 480,900 | 327,800 | 3,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted-Average Grant Date Fair Value | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Nonvested at the beginning of the period (in dollars per share) | $53.73 | ' | ' | $52.68 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Granted (in dollars per share) | $67.31 | ' | ' | $65.97 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Forfeited (in dollars per share) | ' | ' | ' | $55.27 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Nonvested at the end of the period (in dollars per share) | $58.59 | $53.73 | ' | $57.55 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Grant date fair value (in USD) | ' | ' | ' | ' | ' | ' | ' | ' | $11 | ' | ' | ' | ' | ' | $10.60 | ' | ' | ' |
Weighted-average expected option life | ' | ' | ' | ' | ' | ' | ' | ' | ' | '33 months | '45 months | '57 months | ' | ' | ' | ' | ' | ' |
Number of shares outstanding | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 1 | ' | ' | ' |
Method used for estimating grant date fair value | ' | ' | ' | ' | ' | ' | ' | ' | 'lattice model with a Monte Carlo | ' | ' | ' | ' | ' | 'lattice model with a Monte Carlo | ' | ' | ' |
Contractual life | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | '41 months | ' | ' | ' |
Weighted-average risk-free interest rate (as a percent) | ' | ' | ' | ' | ' | ' | ' | ' | ' | 0.30% | 0.50% | 0.70% | ' | ' | 1.60% | ' | ' | ' |
Dividend yield (as a percent) | ' | ' | ' | ' | ' | ' | ' | ' | 1.00% | ' | ' | ' | ' | ' | 1.00% | ' | ' | ' |
Weighted-average expected volatility (as a percent) | ' | ' | ' | ' | ' | ' | ' | ' | 32.00% | ' | ' | ' | ' | ' | 29.00% | ' | ' | ' |
Non-Employee Director Plans | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Outstanding at the beginning of the period (in shares) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 87,300 | ' | ' |
Dividend equivalents (in shares) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 200 | ' | ' |
Outstanding at the end of the period (in shares) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 87,500 | ' | ' |
Weighted-Average Grant Date Fair Value Per Share | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Outstanding at the beginning of the period (in dollars per share) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $33.27 | ' | ' |
Dividend equivalents (in dollars per share) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $71.11 | ' | ' |
Outstanding at the end of the period (in dollars per share) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $33.36 | ' | ' |
Non-employee Director Deferred Cash Compensation, Cash Payout Shares | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Deferred compensation expense to reflect additional deferrals and change in market value (in dollars) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $1 | $1.60 |
NET_EARNINGS_ATTRIBUTABLE_TO_T2
NET EARNINGS ATTRIBUTABLE TO THE ESTEE LAUDER COMPANIES INC. PER COMMON SHARE (Details) (USD $) | 3 Months Ended | |
In Millions, except Per Share data, unless otherwise specified | Sep. 30, 2013 | Sep. 30, 2012 |
Numerator: | ' | ' |
Net earnings attributable to The Estee Lauder Companies Inc. (in dollars) | $300.70 | $299.50 |
Denominator: | ' | ' |
Weighted-average common shares outstanding - Basic | 387.8 | 387.8 |
Weighted-average common shares outstanding - Diluted | 394.9 | 395.5 |
Net earnings attributable to The Estee Lauder Companies Inc. per common share: | ' | ' |
Basic (in dollars per share) | $0.78 | $0.77 |
Diluted (in dollars per share) | $0.76 | $0.76 |
Stock options | ' | ' |
Denominator: | ' | ' |
Incremental common shares attributable to share-based payment arrangements | 5.1 | 5.7 |
RSUs | ' | ' |
Denominator: | ' | ' |
Incremental common shares attributable to share-based payment arrangements | 1.6 | 1.7 |
PSUs based on TSR | ' | ' |
Denominator: | ' | ' |
Incremental common shares attributable to share-based payment arrangements | 0.1 | ' |
MSU | ' | ' |
Denominator: | ' | ' |
Incremental common shares attributable to share-based payment arrangements | 0.3 | 0.3 |
NET_EARNINGS_ATTRIBUTABLE_TO_T3
NET EARNINGS ATTRIBUTABLE TO THE ESTEE LAUDER COMPANIES INC. PER COMMON SHARE (Details 2) | 3 Months Ended | |
In Millions, unless otherwise specified | Sep. 30, 2013 | Sep. 30, 2012 |
Stock options | ' | ' |
Antidilutive Securities Excluded from Computation of Earnings, Per Share | ' | ' |
Antidilutive shares excluded from the calculation of diluted earnings per share | 1.9 | 3.2 |
Contingently Issuable Shares | ' | ' |
Antidilutive Securities Excluded from Computation of Earnings, Per Share | ' | ' |
Antidilutive shares excluded from the calculation of diluted earnings per share | 0.8 | 0.9 |
EQUITY_Details
EQUITY (Details) (USD $) | 3 Months Ended | 3 Months Ended | ||||||||
In Millions, unless otherwise specified | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2013 | Jun. 30, 2013 | Sep. 30, 2013 | Sep. 30, 2013 | Sep. 30, 2013 | Sep. 30, 2013 | Sep. 30, 2013 |
Total stockholders' equity - The Estee Lauder Companies Inc. | Common Stock | Common Stock | Paid-in Capital | Retained Earnings | AOCI | Treasury Stock | Noncontrolling Interests | |||
Increase (Decrease) in Stockholders' Equity | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Balance at the beginning of the period | $3,301.90 | ' | $3,286.90 | $5.60 | $5.60 | $2,289.90 | $5,364.10 | ($157.50) | ($4,215.20) | $15 |
Net earnings | 301.8 | 299.6 | 300.7 | ' | ' | ' | 300.7 | ' | ' | 1.1 |
Common stock dividends - cash | -70.1 | ' | -70.1 | ' | ' | ' | -70.1 | ' | ' | ' |
Other comprehensive income | 61.8 | 69.4 | 61.2 | ' | ' | ' | ' | 61.2 | ' | 0.6 |
Acquisition of treasury stock | -41.8 | ' | -41.8 | ' | ' | ' | ' | ' | -41.8 | ' |
Stock-based compensation | 58.9 | ' | 58.9 | ' | ' | 76 | ' | ' | -17.1 | ' |
Balance at the end of the period | $3,612.50 | ' | $3,595.80 | $5.60 | $5.60 | $2,365.90 | $5,594.70 | ($96.30) | ($4,274.10) | $16.70 |
EQUITY_Details_2
EQUITY (Details 2) (USD $) | 3 Months Ended | 0 Months Ended | 3 Months Ended | 0 Months Ended | 3 Months Ended | 0 Months Ended | |||
In Millions, except Per Share data, unless otherwise specified | Sep. 30, 2013 | Sep. 16, 2013 | Aug. 14, 2013 | Sep. 30, 2013 | Oct. 30, 2013 | Sep. 16, 2013 | Aug. 14, 2013 | Sep. 30, 2013 | Oct. 30, 2013 |
Common Class A | Common Class A | Common Class A | Common Class A | Common Class B | Common Class B | Common Class B | Common Class B | ||
Subsequent Event | Subsequent Event | ||||||||
Class of Stock | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Cash dividends declared per common share (in dollars per share) | $0.18 | ' | $0.18 | ' | $0.20 | ' | $0.18 | ' | $0.20 |
Dividends paid (in dollars per share) | ' | $0.18 | ' | ' | ' | $0.18 | ' | ' | ' |
Purchase of Class A Common Stock (in shares) | ' | ' | ' | 0.9 | ' | ' | ' | ' | ' |
Purchase of Class A Common Stock (in dollars) | $41.80 | ' | ' | $59.50 | ' | ' | ' | ' | ' |
Class B common stock converted into shares of Class A common stock (in shares) | ' | ' | ' | ' | ' | ' | ' | 0.3 | ' |
EQUITY_Details_3
EQUITY (Details 3) (USD $) | 3 Months Ended |
In Millions, unless otherwise specified | Sep. 30, 2013 |
Changes in AOCI, net of tax by component | ' |
Balance at the beginning of the period | ($157.50) |
OCI before reclassifications | 59.9 |
Amounts reclassified from AOCI | 1.3 |
Net current-period OCI | 61.2 |
Balance at the end of the period | -96.3 |
Net Unrealized Investment Gain (Loss) | ' |
Changes in AOCI, net of tax by component | ' |
Balance at the beginning of the period | 0.8 |
OCI before reclassifications | 0.2 |
Net current-period OCI | 0.2 |
Balance at the end of the period | 1 |
Net Derivative Instrument Gain (Loss) | ' |
Changes in AOCI, net of tax by component | ' |
Balance at the beginning of the period | 18.3 |
OCI before reclassifications | -8.7 |
Amounts reclassified from AOCI | -2.5 |
Net current-period OCI | -11.2 |
Balance at the end of the period | 7.1 |
Amounts Included in Net Periodic Benefit Cost | ' |
Changes in AOCI, net of tax by component | ' |
Balance at the beginning of the period | -213.7 |
OCI before reclassifications | -4.1 |
Amounts reclassified from AOCI | 3.8 |
Net current-period OCI | -0.3 |
Balance at the end of the period | -214 |
Foreign currency translation losses | 5.4 |
Translation Adjustments | ' |
Changes in AOCI, net of tax by component | ' |
Balance at the beginning of the period | 37.1 |
OCI before reclassifications | 72.5 |
Net current-period OCI | 72.5 |
Balance at the end of the period | $109.60 |
EQUITY_Details_4
EQUITY (Details 4) (USD $) | 3 Months Ended | |
In Millions, unless otherwise specified | Sep. 30, 2013 | Sep. 30, 2012 |
Reclassification adjustments from accumulated other comprehensive income | ' | ' |
Cost of sales | $544.10 | $539.20 |
Selling, general and administrative | 1,680.20 | 1,527.90 |
Interest expense, net | -13.5 | -15.8 |
Earnings before Income Taxes | 436 | 448.9 |
Benefit (provision) for deferred taxes | -134.2 | -149.3 |
Net Earnings | 301.8 | 299.6 |
Amount Reclassified from AOCI | ' | ' |
Reclassification adjustments from accumulated other comprehensive income | ' | ' |
Net Earnings | -1.3 | ' |
Gain (Loss) on Cash Flow Hedges | Amount Reclassified from AOCI | ' | ' |
Reclassification adjustments from accumulated other comprehensive income | ' | ' |
Earnings before Income Taxes | 3.8 | ' |
Benefit (provision) for deferred taxes | -1.4 | ' |
Net Earnings | 2.4 | ' |
Gain (Loss) on Cash Flow Hedges | Amount Reclassified from AOCI | Foreign currency forward contracts | ' | ' |
Reclassification adjustments from accumulated other comprehensive income | ' | ' |
Cost of sales | 1.4 | ' |
Selling, general and administrative | 2.4 | ' |
Gain (Loss) on Fair Value Hedges | Amount Reclassified from AOCI | ' | ' |
Reclassification adjustments from accumulated other comprehensive income | ' | ' |
Net Earnings | 0.1 | ' |
Gain (Loss) on Fair Value Hedges | Amount Reclassified from AOCI | Settled interest rate-related derivatives | ' | ' |
Reclassification adjustments from accumulated other comprehensive income | ' | ' |
Interest expense, net | 0.1 | ' |
Net Periodic Benefit Cost | Amount Reclassified from AOCI | ' | ' |
Reclassification adjustments from accumulated other comprehensive income | ' | ' |
Earnings before Income Taxes | -5.4 | ' |
Benefit (provision) for deferred taxes | 1.6 | ' |
Net Earnings | -3.8 | ' |
Amortization of prior service cost | -1.1 | ' |
Amortization of actuarial loss | ($4.30) | ' |
STATEMENT_OF_CASH_FLOWS_Detail
STATEMENT OF CASH FLOWS (Details) (USD $) | 3 Months Ended | |
In Millions, unless otherwise specified | Sep. 30, 2013 | Sep. 30, 2012 |
Cash: | ' | ' |
Cash paid during the year for interest | $8.70 | $27.50 |
Cash paid during the year for income taxes | 50.8 | 67.3 |
Non-cash investing and financing activities: | ' | ' |
Incremental tax benefit from the exercise of stock options | -0.8 | -1.8 |
Capital lease obligations incurred | $1.70 | $0.60 |
SEGMENT_DATA_AND_RELATED_INFOR2
SEGMENT DATA AND RELATED INFORMATION (Details) (USD $) | 3 Months Ended | |
In Millions, unless otherwise specified | Sep. 30, 2013 | Sep. 30, 2012 |
Segment | ||
Segment Reporting Information | ' | ' |
Number of operating segments | 1 | ' |
Net Sales: | ' | ' |
Net Sales | $2,675 | $2,549.50 |
Operating Income (Loss) | ' | ' |
Operating Income (Loss) before total charges associated with restructuring activities: | 450.7 | 482.4 |
Operating Income | 449.5 | 482 |
Reconciliation: | ' | ' |
Total charges associated with restructuring activities | -1.2 | -0.4 |
Interest expense, net | -13.5 | -15.8 |
Interest expense on debt extinguishment | ' | -19.1 |
Other income | ' | 1.8 |
Earnings before Income Taxes | 436 | 448.9 |
The Americas | ' | ' |
Net Sales: | ' | ' |
Net Sales | 1,202.40 | 1,182.10 |
Operating Income (Loss) | ' | ' |
Operating Income (Loss) before total charges associated with restructuring activities: | 156 | 172.3 |
Europe, the Middle East and Africa | ' | ' |
Net Sales: | ' | ' |
Net Sales | 891.2 | 824.9 |
Operating Income (Loss) | ' | ' |
Operating Income (Loss) before total charges associated with restructuring activities: | 180.8 | 196.9 |
Asia/Pacific | ' | ' |
Net Sales: | ' | ' |
Net Sales | 581.4 | 542.5 |
Operating Income (Loss) | ' | ' |
Operating Income (Loss) before total charges associated with restructuring activities: | 113.9 | 113.2 |
Skin Care | ' | ' |
Net Sales: | ' | ' |
Net Sales | 1,171 | 1,113.50 |
Operating Income (Loss) | ' | ' |
Operating Income (Loss) before total charges associated with restructuring activities: | 241.6 | 259 |
Makeup | ' | ' |
Net Sales: | ' | ' |
Net Sales | 1,001 | 960.4 |
Operating Income (Loss) | ' | ' |
Operating Income (Loss) before total charges associated with restructuring activities: | 166.3 | 161.3 |
Fragrance | ' | ' |
Net Sales: | ' | ' |
Net Sales | 367.4 | 347.6 |
Operating Income (Loss) | ' | ' |
Operating Income (Loss) before total charges associated with restructuring activities: | 36.9 | 53.4 |
Hair Care | ' | ' |
Net Sales: | ' | ' |
Net Sales | 124.8 | 113.9 |
Operating Income (Loss) | ' | ' |
Operating Income (Loss) before total charges associated with restructuring activities: | 8.4 | 10.7 |
Other | ' | ' |
Net Sales: | ' | ' |
Net Sales | 10.8 | 14.1 |
Operating Income (Loss) | ' | ' |
Operating Income (Loss) before total charges associated with restructuring activities: | ($2.50) | ($2) |